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Abstract 
Neuronal differentiation is an important process during human development and 
regenerative medicine.  One factor linked to differentiation of neurons in vivo as well as 
in vitro is the generation of reactive oxygen species (ROS).  In addition, 
neurodegeneration is the disease of the old age that is currently affecting millions.  
Although the etiology of each neurodegenerative disease differs, oxidative stress has been 
the common factor leading to neuronal death.  PC12 cells differentiate into sympathetic-
like neurons in the presence of nerve growth factor (NGF).  Once terminally 
differentiated, PC12 cells undergo apoptosis following NGF deprivation with similar 
characteristics of sympathetic neuronal death.  These properties make them useful for 
studying in vitro neuronal differentiation and apoptosis.  In addition, NADPH oxidase has 
been implicated in the differentiation and apoptosis of this cell line through production of 
reactive oxygen species (ROS).  However, the subunits involved in both processes have 
not been identified.  A series of studies were designed to examine the effect of 
physiological activator (angiotensin II) and pharmacological inhibitor (DPI) of NADPH 
oxidase on PC12 cell differentiation and apoptosis.  The differentiation study has 
revealed that the putative subunits involved in the early phases may be Nox4 and p67-
phox, with subsequent recruitment of Nox1 and p47-phox during the later stages of 
differentiation.  NGF withdrawal led to an increase in Nox1, p47-phox and p67-phox 
suggesting a role for those subunits in PC12 cell apoptosis. Therefore, these data confirm 
and extend previous results that suggest that neuronal but not phagocytic NADPH 
oxidase is involved in neurogenesis and apoptosis. 
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Introduction 
 
Apoptosis in tissue homeostasis and pathogenesis 
 
In 1964, Lokshin and Williams used the expression “programmed cell death” 
(PCD) to describe the breakdown of silkworm intersegmental muscles during 
metamorphosis (reviewed in Gusev and Skvortsova, 2003).  In 1972, the word 
“apoptosis” was coined from the Greek words apo = from and ptosis = falling describing 
the fall of dead leaves from trees in autumn (Kerr et al., 1972).  Subsequently, extensive 
research has been focusing on the molecular mechanisms underlying cell suicide in 
development and disease. The motivation was the attempt to exploit programmed cell 
death for therapeutic purposes (reviewed in Elmore, 2007).  During development, the 
histogenic remodeling ensures optimal nerve innervations of target organs.  In addition, it 
provides an essential mechanism for elimination of transitory organs in tissue remodeling 
and homeostasis (Levi-Montalcini et al., 1968; Saunders, 1966).  According to the 
neurotrophic theory, growing neurites reaching their targets become dependent on trophic 
factors for survival and differentiation (Levi-Montalcini et al., 1968).  These substances 
are secreted in limited amount by target cells.  Subsequently, neurons receiving sub-
threshold amount of neurotrophic factor are destined to die via apoptosis (Levi-
Montalcini et al., 1968).  Actually, up to 80% of neurons formed during embryogenesis 
are destined to undergo PCD in the early postnatal development (Oppenheim, 1991).  The 
NGF dependence can be recapitulated in vitro, as neonatal sympathetic and sensory 
neurons require NGF for survival.  NGF antibodies administered during the phase of 
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target field innervations led to the loss of these neurons, whereas exogenous NGF rescued 
neurons that would have been otherwise lost (Levi-Montalcini, 1987).  Although PCD is 
an integral mechanism during embryogenesis, it has been involved in detrimental 
neuronal loss in adult life.  In fact, PCD activation triggers progressive neurodegeneration 
as detected in Alzheimer, Parkinson’s diseases, amyotrophic lateral sclerosis (ALS) and 
acute loss of neurons as depicted following a stroke (reviewed in Maurer et al., 1997; Lee 
et al., 2001; Siderowf and Stern, 2003). 
Epidemiology of Neurodegeneration  
The incidence of neurodegeneration has been increasing tremendously in the past 
few decades.  It is mainly due to the demographic shift in “aging America.” In addition, 
the increase in life expectancy has put the baby boomers at higher risk of developing 
brain degenerative diseases (Dychtwald, 1989).  Neurodegeneration is characterized by 
progressive death of neurons in the central and peripheral nervous systems.  Clinically, it 
is manifested by a gradual regression of body functions that are under the control of the 
diseased areas (reviewed in Siderowf and Stern, 2003; Boksay et al., 2005).  A number of 
environmental and genetic risk factors have been proposed, however none were 
confirmed to be the definite culprit (Mayeux, 2003).  Nevertheless, the oxidative free 
radical theory has gained common ground in the etiology of neurodegeneration (Coyle 
and Puttfarcken, 1993).  Although a milestone has been reached in understanding this 
condition, a promising cure to the ailment is still lagging behind.     
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Oxidative stress in neurodegeneration 
Finding a cure for pathological neurodegeneration has been the preoccupation of 
numerous clinicians and researchers.  Many therapeutic substances under clinical studies 
were used for that purpose, such as NMDA-antagonists, antioxidants and growth factors 
(Shigeno et al., 1991; Fisher et al., 1995; Li et al., 2002). The results came back 
disappointing, as most likely in vitro success does not necessarily replicate itself in vivo.  
Although each neurological condition exhibits a distinct etiology, there are common 
grounds to all brain degenerative conditions.  Therefore, it is vital to understand the 
pathological mechanisms and their interactions in order to piece in the enigma behind 
neurodegeneration.  One insight would be to understand the common neuronal 
intracellular signaling under different pathological conditions.  Oxidative stress 
involvement in the pathophysiology of numerous diseases has created a research 
emphasis on understanding redox signaling.  The latter has been implicated in a wide 
spectrum of cellular responses ranging from differentiation, to senescence and apoptosis 
(Thannickel et al., 2000; Droge, 2002).  
Reactive oxygen species 
Reactive oxygen species (ROS) and free radicals are frequently used 
interchangeably to refer to species such as superoxide O2.-, hydrogen peroxide H2O2, and 
hydroxyl radical ·OH.  Prior to the middle of the 20th century, free radicals were unknown 
to clinicians and biologists of that time.  In 1954, Rebecca Gerschman and her scientific 
group introduced the concept of reactive oxygen species as toxic elements in aerobes, and 
explained that oxygen toxicity is due to the formation of free radicals (reviewed in 
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Gutteridge and Halliwell, 2000).  This was followed by the identification of the 
superoxide dismutase (SOD) by McCord and Fridovich in 1968.  Afterward, the 
emergence of scientific disciplines has contributed further to the understanding of ROS 
and their involvement in disease pathology (reviewed in Gutteridge and Halliwell, 2000).  
Sources of reactive oxygen species (ROS) 
The mitochondrial respiratory chain is the major site of cellular ROS production 
under normal physiological conditions.  Electrons produced by the metabolism of 
glucose, fatty acids and proteins flow through the mitochondrial electron-transport chain 
leading to ATP production (Lehninger and Kennedy, 1948).  Although ROS are created 
as part of normal respiration, their accumulation beyond physiological levels leads to 
oxidative stress (Droge, 2002).  The mitochondria have limited DNA repair machinery, 
which makes mitochondrial DNA more prone to oxidant insult than its nuclear 
counterpart (Croteau and Bohr, 1997).  Upon oxidative stress, the integrity of the 
mitochondrial membranes is compromised leading to cytochrome C release and caspase 
cascade activation (Droge, 2002). NADPH oxidase and xanthine oxidase are non-
mitochondrial sources of ROS in various tissues including the vascular system and 
smooth muscle cells (Tammariello et al., 2000; Hilburger et al., 2005; Galbusera et al., 
2006; reviewed in Quinn et al., 2006).  The two oxidases are known sources of ROS 
implicated in many pathological conditions such as bacterial infection and hypertension 
(Rothfork et al., 2004; Delano et al., 2006).  In fact, the oxidative burst generated by the 
oxidases disturbs cellular structure and functional integrity by oxidative degradation of 
cellular DNA, proteins, and lipids (Ames et al., 1993). 
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ROS as second messengers 
Superoxide anion (O2·-) and hydrogen peroxide (H2O2) are produced in many cell 
types in response to an array of extracellular stimuli. These include peptide growth 
factors, cytokines, agonists of G protein–coupled receptors, and shear stress (reviewed in 
Rhee, 1999; Rhee et al., 2000).  The incomplete reduction of O2 produces the superoxide 
anion (O2·-), which is later enzymatically or non-enzymatically converted to H2O2 
(reviewed in Rhee, 1999).  Since H2O2 is a small and diffusible molecule, it is believed to 
act as a second messenger under subtoxic conditions by targeting various proteins. These 
include protein kinases, protein phosphatases, transcription factors, phospholipases, and 
G proteins (reviewed in Rhee et al., 2000).  Unlike other second messengers, H2O2 exhibit 
an unconventional protein modification by targeting sulfhydryl groups of cystein 
residues, which tend to be vulnerable to oxidation (Kim et al., 2000).  Subsequently, 
conformational, structural, and kinetic alterations induce activation or inhibition of the 
protein (McCubrey and Franklin, 2006).  
NADPH oxidase: innate immunity and beyond 
The phagocytic NADPH oxidase  
 
The phagocytic NADPH oxidase is a crucial enzyme part of the innate immunity 
as the phagocytes are the first line of defense against bacterial invasion (Henderson and 
Chappell, 1996).  Individuals with genetic deficiencies or mutations in any of the oxidase 
subunit genes exhibit recurrent life-threatening infections of chronic granulomatous 
disease (CGD) (reviewed in El-Banna et al., 2005).  CGD is an inherited disorder in 
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which phagocytes fail to destroy invading pathogens (Bridges et al., 1959).  Upon 
microbial infection, activated phagocytes engulf the pathogen, and eradicate its 
biomolecules by toxic oxygen molecules causing a complete lysis (Babior, 1999).  In 
fact, the reactive oxygen species are generated through a stimulus-dependent activation of 
the membrane-bound NADPH oxidase.  It involves the reduction of oxygen (O2) by 
addition of an unpaired electron to the outermost shell using NADPH as an electron 
donor producing the superoxide (Gabig and Lefker, 1985).  The presence of the orphan 
electron disturbs the stability of the O2 ions, which increases its reactivity to pair the 
electron (Sawyer and Valentine, 1981).  The superoxide acts as a precursor for reactive 
oxygen species (ROS).  By itself, it is a weak oxidant; however when it converts to a 
more potent form it becomes toxic to the organism (Dahl and Richardson, 1978).  In fact, 
hydrogen peroxide causes lipid peroxidation of cell membranes by reacting with reduced 
transition metals to generate the reactive hydroxyl radicals (Kellogg and Fridovich, 
1975).  Although hydroxyl radicals are short-lived, they are considered the most injurious 
radicals (Knight, 2000).  As a defense mechanism against hydrogen peroxide, aerobic 
cells use the enzyme catalase, which decomposes hydrogen peroxide into water and 
oxygen (Repine et al., 1981; Morehouse et al., 1983).  
 
Cytochrome b558 is necessary for the activation of NADPH oxidase 
NADPH oxidase is a multi-subunit complex enzyme whose activation is under 
tight control (Lassegue and Clempus, 2003).  At rest, NADPH oxidase subunits are 
partitioned between the plasma membrane and the cytosol (Lassegue and Clempus, 
2003).  There are two membrane-bound subunits which include gp91-phox and p22-
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phox.  The cytosolic complex is composed of p47-phox, p67-phox, p40-phox and a small 
G-protein Rac1 or Rac2 (Joneson and Bar-Sagi, 1998; Lassegue and Clempus, 2003).  
Gp91-phox (also known as Nox2) and p22-phox dimerize in a molar ratio of 1:1 to form 
cytochrome b558 the catalytic core of the enzyme (Huang and Kleinberg, 1999) (Fig. 1).  
 The stability of the cytochrome relies on gp91-phox binding to its adapter protein 
p22-phox prior to their insertion into the plasma membrane.  Mutation in either subunit 
has resulted in absence of both proteins on the cell membrane (Babior et al., 2002).  
According to Yu and coworkers (1999), the cytochrome b558 contains two heme 
molecules in its transmembrane domain and their attachment to cytochrome b558 occurs 
by means of four histidines.  In addition, the cytochrome b558 encloses an NADPH and an 
FAD binding sites on its cytoplasmic C-terminus, where NADPH is the electron donor 
and FAD is the electron carrier (Chanock et al., 1994; Krause, 2004).  In fact, deletion of 
FAD causes loss of superoxide generation and restoration of NADPH oxidase activity is 
detected after FAD replenishment. Moreover, use of flavin antagonist such as 
diphenylene iodonium (DPI) eliminated superoxide production, which confirmed the 
presence of a flavin in cytochrome b558 (Babior and Peters, 1981). Upon enzyme 
activation, NADPH releases two electrons to FAD, which are taken by the twin hemes in 
cytochrome b558.  Across the membrane, two O2 molecules accept the electrons and 
produce superoxide anions (Lassegue and Clempus, 2003).  To counterbalance the 
negative charges transversely, proton efflux takes place in parallel direction through 
voltage-gated proton channels.  The identity of the channels remains questionable as 
some argue that it is part of the oxidase, others debate that is coupled to it (Kimball and 
Saier, 2002; DeCoursey et al, 2002).  Beside the plasma membrane, the cytochrome b558 
  9 
has been localized to cytoplasmic vesicles delivered to the cell membrane by fusion 
(Lassegue and Clempus, 2003).  This led to the hypothesis that superoxides are released 
inside vesicles and transported out via anion channels; and that membrane-permeable 
hydrogen peroxide diffuses out easily (Lynch and Fridovich, 1978; Forman et al., 2002; 
Han et al., 2003). 
 
Role of p47-phox-phox in NADPH oxidase activation 
The p47-phox subunit is a multi-domain protein that harbors a number of protein-
protein interaction elements.  The most prominent are the SH3 domains, which play a 
vital role in NADPH oxidase activation (de Mendez et al., 1997).  SH3 homology 
domains are 60-amino acid tandem repeats which bind to proline-rich regions (PRR) of a 
target protein and mediate localization of signaling molecules (Finan et al., 1996; 
Karathanassis et al., 2002).  In addition, NADPH oxidase activation engages a series of 
protein-protein and protein-lipid interactions and involves two key events: 
hyperphosphorylation of p47-phox subunits and GTP/GDP exchange on Rac1 
(Groemping et al., 2003).  These two incidents trigger the migration of the cytosolic 
subunits to the membrane and subsequent binding to the catalytic core at SH3 homology 
domains of both p47-phox and p67-phox (Leto et al., 1994).  Functional and structural 
studies have demonstrated the existence of p47-phox regulatory domains that direct the 
activation and inactivation of the enzyme (Ago et al., 2003; Groemping et al., 2003).   
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Figure 1. Schematic illustration of NADPH oxidase at rest. Membrane-bound subunits 
gp-91-phox (also known as Nox 2) and p22-phox form the catalytic core (cytochrome 
b588). The cytosolic subunits p47-phox, p67-phox and p40-phox reside in the cytoplasm. 
The small GTPase Rac is part of the enzyme activation. http://www.juntendo.ac.jp 
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One worth mentioning is the autoinhibitory region (AIR) that folds on itself masking the 
SH3 domains in unstimulated cells.  The phosphorylation of p47-phox C-terminal by 
protein kinase C (PKC) and serine/threonine protein kinase Akt is critical for inducing a 
conformational change and subsequent release of the SH3 domains (Ago et al., 2003).  
Additionally, Yamamoto et al. (2007) showed that arachidonic acid (AA) enhances the 
SH3-mediated binding of p47-phox to p22-phox.  In fact, kinetic studies reported that an 
anionic amphiphile such as arachidonic acid at high concentrations (50-100 µM) activates 
p47-phox in cell-free system and induces a conformational change without the 
hyperphosphorylation by PKC and Akt.  At lower concentrations (50-75 µM), AA acts in 
synergism with PKC to activate p47-phox by the above-described mechanisms (Shiose 
and Sumimoto, 2000).  Another critical domain for the binding of the cytosolic subunits 
to the membrane counterparts is the phagocytic oxidase homology domain (PX).  This is 
a lipid-binding domain that connects to membrane phosphatidylinositide phosphates by 
nonspecific electrostatic interactions and subsequent membrane insertion of hydrophobic 
residues (Stahelin et al., 2003).  The conformational change induced by phosphorylation 
of p47-phox releases PX domain to bind to phosphatidylinositol lipids on cell membrane. 
 Conflicting roles for p47-phox have been reported.  Functional studies have 
shown that p47-phox activation increased its binding to p67-phox by 100-fold, and 
subsequently a firmer attachment took place between Rac and p67-phox. These data grant 
p47-phox a function of a regulator rather than a direct activator of the enzyme (Freeman 
and Lambeth, 1996).  On the same note, in p47-phox-deficient phagocytes translocation 
of p67-phox failed to occur whereas p47-phox migrated independently to the cell 
membrane in p67-phox -defective cells (Heyworth et al., 1991; Dusi et al., 1996).  
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Nevertheless, others depicted partial activation of NADPH oxidase in vivo in complete 
absence of p47-phox and normal physiological levels of p67-phox and Rac (Cross and 
Curnutte, 1995). Conversely, NADPH oxidase function was independent of p47-phox in 
vitro, granted high concentrations of p67-phox and Rac were provided (Freeman and 
Lambeth, 1996).  On the other hand, p47-phox facilitates electron flow through 
interacting with p22-phox cytoplasmic tail; however, in the absence of p47-phox subunit 
NADPH oxidase still produced ROS presumably by different pathways (Cross and 
Curnutte, 1995). This suggests that p47-phox is necessary but not sufficient for NADPH 
oxidase activation. 
 
Role of p67-phox-phox in NADPH oxidase activation 
The binding of p67-phox to p47-phox is vital for the translocation of the 
cytoplasmic complex to the membrane (De Leo and Quinn, 1996).  The unfolding of p47-
phox and the subsequent release of the SH3 domains expose a binding site for p67-phox.  
Leto et al. (1994) reported that SH3 domain C-terminal of p67-phox is crucial for p47-
phox binding.  Deletion of the C-terminal, but not of the N-terminal, of SH3 domain 
abolished the binding of p67-phox to p47-phox.  On another note, p67-phox activates 
NADPH oxidase by attaching to the cytochrome b558 and directing the flow of electrons 
from NADPH to FAD (Cross and Curnutte, 1995; Freeman and Lambeth, 1996).  In fact, 
in vitro complementation study of p67-phox-deficient CGD mutants proposed that this 
subunit is the limiting factor in oxidase assembly and activation as addition of exogenous 
p67-phox restored cytochrome b558 activity (Vergnaud et al., 2000).  Miyano and 
colleagues (2006) showed that p67-phox- requires the small GTPase Rac in order to 
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activate NADPH oxidase.  The same group demonstrated that Rac binds to the N-
terminal region of p67-phox at the membrane and subsequently induces a tighter binding 
between p67-phox and p22-phox.  In addition, the small GTPase facilitated membrane 
localization of p67-phox when interaction between p67-phox and p47-phox was deficient 
(Miyano et al., 2006). 
 
Role of p40-phox in NADPH oxidase activation 
 
The literature compiles inconsistent information about the precise role of p40-
phox in NADPH oxidase activation.  P40-phox increases oxidase activity by increasing 
the binding affinity of p67-phox- for p47-phox and of p40-phox for cytochrome b558 
(Cross, 2000).  However, at higher physiological concentrations it down-regulates the 
activity of the enzyme by competing with p67-phox for the C-terminal SH3 domain of 
p47-phox (Sathyamoorthy et al., 1997).  This competitive binding between p67-phox and 
p40-phox is described as the modulator of NADPH oxidase activity (Ito et al., 1996).  In 
addition, deficiencies in either p47-phox or p67-phox detected in autosomal recessive 
forms of CGD showed decreased translocation of p40-phox to the membrane (Dusi et al., 
1996).  p40-phox contains a conserved structural stretch of nearly 130 amino acids in the 
PX domain that binds exclusively phosphatidylinositol 3-phosphate for penetration in the 
cell membrane with the help of cytochrome b558 (Heyworth et al., 1991; Dusi et al, 1996; 
Stahelin et al., 2003).  This suggests that docking requires both binding to the cytochrome 
b558 as well as to the presence of PX domain.  It is noteworthy that p40-phox is associated 
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with NADPH oxidase of phagocytic origin and has not been detected in NADPH oxidase 
homologs of non-immune cells (Sathyamoorthy et al., 1997). 
The small GTPase Rac in NADPH oxidase activation 
Rac small GTPases are implicated in cytoskeleton regulation, mitogenesis, and 
superoxide generation by NADPH oxidase (Abo et al., 1991; Dusi et al., 1996; Kim et al., 
1998; Joneson and Bar-Sagi, 1998; Bompard et al., 2005; Cheng et al., 2006).  They 
belong to the Ras family involved in intracellular signaling mainly of the tyrosine 
receptor kinase.  In addition, Rac bears a Ras effector-homolog domain comprised of 26-
48 amino acids that interacts with Raf-1 amino-terminal regulatory region of Mitogen-
Activated Protein (MAP) kinase-signaling pathway (Warne et al., 1993).  Mutations in 
the homology region of Rac prevented the binding of oxidase cytosolic subunits, 
suggesting that the homologous residues of Rac are crucial for NADPH oxidase assembly 
(Freeman et al., 1994).  In naïve neutrophils, Rac binds to GDP and dimerizes with Rho-
GDI (Guanine nucleotide Dissociation Inhibitor) (Price et al., 2002).  Exposure of the cell 
to pathogens evokes the assembly of NADPH oxidase as well as the activation of guanine 
nucleotide exchange factors (GEF).  GEF releases Rac from its inhibitor Rho-GDI and 
exchanges GDP for GTP, a prerequisite for Rac activation (Price et al., 2002).  In 
addition, Rac has three critical binding sites necessary for NADPH activation.  The 
insertion, the effector, and the C-terminus prenylated regions bind to the cytochrome b558, 
p67-phox, and cell membrane, respectively (Freeman et al., 1996).  The insertion region 
is a 12-amino acid stretch (residues 124-136) that is involved in regulating the oxidase 
kinetics.  In fact, point mutations and deletions in this region decreased NADPH oxidase 
activity tremendously (Freeman et al., 1996).  The effector region (residues 26-45), 
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homolog to Ras effector site, is vital to p67-phox binding.  Mutations of amino acids in 
that region abolished the ability of Rac to support superoxide generation (Freeman et al., 
1994).   
Non-phagocytic NADPH oxidase 
Over the past decade, several studies detected analogues of NADPH oxidase in 
various non-immune tissues, mainly of mesodermal origin (Babior, 1999).  The homologs 
were shown to be involved in superoxide generation in several organs, including the 
colon, the kidney, and the vascular system (Lassegue and Clempus, 2003).  The 
discovery of NADPH oxidase in non- phagocytic cells drew question marks around its 
precise function.  Consequently, efforts were invested in unfolding the enigma behind the 
newly discovered oxidase.  The initial work focused on identifying homologs of gp91-
phox.           
Gp91-phox homolog was cloned and identified by two independent groups.  
Mox1 (for mitogenic oxidase-1) was implicated in regulating fibroblast growth and 
transformation (Suh et al., 1999).  Parallel investigation led to the discovery of NOH-1 
(for NADPH oxidase homolog-1) that acted as a built-in proton channel upon oxidase 
activation (Banfi et al., 2000).  A common classification of Nox (for NADPH oxidase) 
was adopted afterward to prevent further disparity (Lassegue et al., 2001).  Subsequently, 
four homologs: Nox1, Nox3, Nox4, and Nox5 were identified in non-immune cells 
(Banfi et al., 2003).  Nox homologs exhibit a low constitutive activity that is subject to 
regulation by different stimuli (Lassegue and Clempus, 2003).  In addition, the low levels 
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of superoxide and H2O2 produced in response to cellular growth factors are integral 
regulators of a wide range of intracellular signaling pathways (Rhee et al., 2000).  
NADPH oxidase in neurons 
NADPH oxidase subunits were detected in sympathetic neurons at mRNA and 
protein levels; however the identity of the catalytic subunits was not established 
(Tammariello et al., 2000; Hilburger et al., 2005).  Optical sectioning using laser 
scanning confocal microscopy confirmed the subcellular localization of NADPH oxidase 
to resemble the one of resting phagocytic cells.  Gp91-phox and p22-phox were 
membrane-bound while p47-phox and p67-phox were localized to the cytoplasm 
(Hilburger et al., 2005).  Another localization study using immunocytochemistry detected 
NADPH subunits concentrated in the hippocampus, cortex, amygdala, striatum, and 
thalamus of a mouse brain (Serrano et al., 2003). Immunocytochemical analysis of 
cultured hippocampal neurons indicated that all NADPH oxidase proteins were present in 
the cell body as well as in the dendrites.  In addition, stimulation of hippocampal slices 
with phorbol esters triggered the translocation of the cytoplasmic NADPH oxidase 
proteins to the membrane concomitant with an increase in superoxide production 
(Tejada-Simon et al., 2005).  Noh and Koh (2000) demonstrated using RT-PCR and 
western blot analyses that cultured cortical neurons also express subunits of NADPH 
oxidase at low levels.  Upon exposure to toxic amounts of zinc, levels of NADPH 
oxidase subunits substantially increased.  In addition, zinc exposure induced translocation 
of p47-phox and p67-phox subunits to the membrane which is a characteristic event of 
NADPH oxidase activation (Noh and Koh, 2000).    
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Nox1 
Nox1 is highly expressed in the colon although additional expression sites were 
depicted to a lesser degree (Suh et al., 1999; Banfi et al., 2000).  In fact, it has been 
localized to the uterus and the prostate and induced in some cell types by growth factors 
(Banfi et al., 2000).  Nox1 is a 65-kDa protein that is 58% identical to gp91-phox 
(Lambeth et al., 2000).  No precise function has been attributed to Nox1 as it exhibits 
differential role in various tissues.  However, some argued that it is involved in innate 
immunity of the colon epithelial cells, as they are the first to encounter pathogens and 
toxins harbored in ingested food (Geiszt et al., 2003).  As part of the gut inborn immune 
system, Nox1 synthesis is upregulated by inflammatory cytokines to increase superoxide 
production (Krause, 2004).  Others have shown that Nox1 is involved in redox signaling 
leading to tumorgenesis and vascular smooth muscle hypertrophy (Suh et al., 1999; 
Katsuyama et al., 2005). Conversely, Nox1-induced superoxide generation was shown to 
be independent of cell stimulants; however it was amplified by cell treatment with protein 
kinase C (PKC)-activator phorbol 12-myristate 13-acetate PMA (Takeya et al., 2003). 
Nox1 has been detected in undifferentiated and differentiated PC12 cells at the 
mRNA level (Ibi et al., 2006).  Following trophic factor addition, nox1 transcript 
increased producing a peak at 72 hours.  The increase in mRNA levels paralleled the 
enhancement in neurite outgrowth (Ibi et al., 2006).  In addition, superoxide production 
increased by twofold at 72 hours; however when ROS generation was measured short-
term, the fluorescence hit its highest point at 10 minutes after which it declined to the 
basal level (Ibi et al., 2006).  This is in accordance with previous observation, where 
nerve growth factor (NGF) was shown to increase superoxide generation producing a 
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climax of 2’,7’-dichloro-fluorescein diacetate (DCF) fluorescence at 10 minutes 
(Suzukawa et al., 2000).  
 
Nox4 
Nox4 is a 578-amino acid protein that exhibits 39% homology to gp91-phox 
(Nox2). It retains the conserved membrane-spanning domains and the binding sites for 
heme, FAD, and NADPH (Lassegue and Clempus, 2003; Shiose et al., 2001).  Renox, a 
renal Nox homolog, was identified in mouse kidney proximal tubular cells.  It was 
described as an oxygen sensor that controls Epo gene expression (Ebert and Bunn, 1999; 
Geiszt et al., 2000).  In 2001, Shiose and coworkers reported the cloning of a human 
cDNA that encodes Renox, which was given Nox4 nomenclature conforming to the 
consensus terminology for the Nox family.  In fact, these investigators proposed that 
nox4 expression is limited to fetal and adult human kidneys.  In addition, the protein was 
predominantly detected in distal tubular cells, which is a novel expression site for Nox4 
(Shiose et al., 2001).  However, differences in species and experimental methods could 
have accounted for the inconsistency of these results.  The fetal expression of nox4 
transcript in the kidney suggests a role for Nox4 other than oxygen sensing and Epo 
expression regulation since fetal kidneys produce limited Epo.  This implies that Nox4 
could be implicated in the regulation of other cellular activities (Rodriguez et al., 1995).  
Furthermore, Nox4 is involved in vascular pathology of renal diseases.  Gorin et al. 
(2004) reported that Nox4 mediates angiotensin II-induced kidney hypertrophy and 
increased fibronectin synthesis; two characteristics of early diabetic nephropathy (Gorin 
et al., 2005).           
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 Unlike Nox1, Nox4 is constitutively active.  Consequently, the level of ROS 
generation via Nox4 might as well be dependent on nox4 expression and/or post-
translational modification such as glycosylation (Lambeth, 2004).  Geiszt et al. (2000) 
showed that Nox4 constitutively produces H2O2, which is a by-product of superoxide.  
The nearly ubiquitous presence of Nox4 and its ROS production suggest a wide 
involvement in cellular activities ranging from cell division and differentiation to 
vasodilatation and insulin signaling.  In addition, Nox4 contributes to ischemic damage as 
middle cerebral artery occlusion in mice resulted in a significant increase in cortical 
Nox4 (Vallet et al., 2005).   
NADPH oxidase in cellular differentiation and apoptosis 
Recent reports suggest that Nox1 is involved in apoptosis, whereas Nox4 is 
implicated in differentiation and the later stages of apoptosis (Kobayashi et al., 2004; 
Wolin, 2004; Griendling, 2006).  In fact, Nox1 has been associated with apoptosis and 
cellular morphogenesis of sinusoidal endothelial cells (SEC) and non-tubulogenic 
endothelial cell line (NP31), respectively (Kobayashi et al., 2004).  However, Nox4 was 
found to be an inducer of apoptosis in human aortic smooth muscle cells and a necessary 
element for differentiation of vascular smooth muscle cells (Pedruzzi et al., 2004; 
Griendling, 2006).  The differential activity exhibited by Nox homologs could be related 
to the amount and rate of reactive oxygen species produced.  Indeed, the rate of reactive 
oxygen species generation in non-phagocytic NADPH oxidase as well as their relative 
abundance is different from those of phagocytic cells (Droge, 2002).  Unlike the 
cytotoxic effect of gp91-phox that shuttles massive superoxides outside the cell, Nox2- 
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homologs generate lower intracellular levels of ROS that may act as signaling molecules 
(Thannickal et al., 2000; Mitsushita et al., 2004). 
NADPH oxidase activators and inhibitors significantly modulate enzyme’s activity 
 
Angiotensin II is a potent activator of NADPH oxidase.  It exerts its action 
through two types of G-protein coupled receptors AT1 and AT2 (Nakajima et al., 1995).  
The exact mechanism(s) by which angiotensin II increases NADPH oxidase activity is 
still unclear.  In addition, AT2 receptor activation has been implicated in cellular 
differentiation and apoptosis and use of AT2 inhibitors have aborted or delayed its effects 
(Yamada et al., 1996; Meffert et al., 1996).  Furthermore, diphenylene iodonium (DPI) is 
a non-specific NADPH oxidase inhibitor that is widely utilized by researchers.  The 
inhibitory effect of DPI is initiated when electron transport through the flavin moieties of 
the oxidase causes reduction of DPI to its radical form.  This is followed by irreversible 
phenylation of either the flavin or adjacent amino acid abolishing the enzyme’s activity 
(Pullar and Hampton, 2002).  DPI application inhibited ROS production, delayed 
apoptosis, and neurite outgrowth in neuronal cells (Babior and Peters, 1981; Suzukawa et 
al., 2000; Tammariello et al., 2000; Matsunaga et al. 2005; Balcerczyk et al., 2005). 
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Angiotensin II 
 
Historical Background 
 
In 1898, Tigerstedt and Bergman introduced the first notion of blood pressure 
regulation following the discovery of “rennin,” which was isolated from saline rabbit 
kidney extracts (reviewed by Phillips and Schmidt-Ott, 1999).  As subsequent trials failed 
to confirm Tigerstedt and Bergman's findings, scientists lost interest in the newly 
discovered substance.  In 1934, Harry Goldblatt published a breakthrough study showing 
that constriction of either one or both renal arteries led to hypertension.  In addition, he 
demonstrated that severe renal ischemia secondary to hypertension was due to increased 
renin release (Goldblatt et al., 1934).  In 1940, two independent investigators isolated a 
vasoconstrictor substance from the kidney.  The group in Argentina named it 
“hypertensin,” while the American group called it “angiotonin” (Braun-Menendez et al., 
1940; Page and Helmer, 1940).  In 1958, upon discovering of their common finding the 
two groups agreed on the chimerical term angiotensin (reviewed in de Gasparo et al., 
2000). Subsequently, more effort was invested on unfolding the sequential events leading 
to angiotensin synthesis and activation.  
 
Physiological action of Angiotensin II 
 
Braun-Menendez and coworkers (1940) showed that the enzyme renin 
enzymatically cleaves a substance called angiotensinogen to release a decapeptide, 
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discovered later as angiotensin I by Leonard Skeggs.  Angiotensin I is then hydrolyzed to 
form a powerful octapeptide substance known as angiotensin II.  The sequential action of 
this dual hydrolysis system is known as the renin-angiotensin system (RAS).  RAS is a 
major regulator of salt and fluid homeostasis and plays a crucial role in the control of 
blood pressure and modulation of sympathetic nerve activity (Skeggs et al., 1956).  
Angiotensinogen, which is a 453 amino acid protein, circulates constitutively in 
the blood stream in an inactive form.  However, the conversion of angiotensinogen into 
angiotensin II is under tight regulation to prevent overproduction of the hormone and 
possible inopportune effects (Thomas, 1999).  Angiotensin II exerts its activity through 
AT1 and AT2
 
cell-surface receptors, which bear approximately 34% homology 
(Mukoyama, 1993; Gunther, 1984).  Hydropathy plot analysis indicated that AT1 and 
AT2 receptors are seven-spanning membrane receptors that have been cloned and 
characterized (reviewed in de Gasparo et al., 2000).  Through binding to AT2 receptors, 
angiotensin II elicits intracellular signaling linked to cellular differentiation and apoptosis 
through long-term regulation of gene expression (Thomas, 1999). 
 
AT2 receptor and its signaling pathways 
AT2 receptor is a 363 amino acid peptide.  Studies on distribution of angiotensin 
II receptors described AT2
 
receptors being a dominating receptor subtype in fetal and 
neonatal tissues, and in cell lines of neuronal origin (Millan et al., 1991; Grady et al., 
1991).  After birth, AT2 receptor expression subsides while AT1 receptor expression 
increases dramatically (Tsutsumi and Saavedra, 1991; Wolf, 2002).  However, a detailed 
distribution study located AT2 in adult rat brain and depicted a predominant expression 
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in areas comprising the sensory and motor systems as well as behavior and emotions 
(Lenkei et al., 1997).  In fact, AT2- knockout mice showed anxiety-like symptoms, 
muscle weakness and reduced drinking response (Hein et al., 1995; Okuyama, 1999).  In 
addition, increased AT2 receptor expression was documented under pathophysiological 
conditions such as wound, mechanical injury, and brain ischemia (Nio et al., 1995; 
Steckelings et al., 2005).  Moreover, AT2 receptors have been implicated in cell 
proliferation inhibition, and induction of cellular differentiation and apoptosis (Stoll et 
al., 1995; Meffert et al., 1996; Wolf, 2002).  Conversely, AT2 receptor promoted axonal 
regeneration after nerve transection (Lenkei et al., 1997).  Indeed, elevated AT2 
expression was linked to an angiotensin II-induced axonal regeneration by increasing 
neuronal fibers around the lesion (Lucius et al., 1998).  The specific mechanisms of the 
AT2-induced effects are still unknown; however, antiproliferative and axonal 
regeneration actions are believed to ensue through signaling leading to cytoskeleton 
rearrangement during neuronal differentiation (Gendron et al., 2003).  Although 
structurally related to G-protein coupled receptors, activation of AT2 receptor seems to 
stimulate non-classical signaling cascades.  Nouet and Nahmias (2000) have described 
three major cascades of intracellular signaling: (1) activation of protein phosphatases 
leading to protein dephosphorylation (2) regulation of the nitric oxide (NO)–cGMP 
system; and (3) stimulation of phospholipase A2 (PLA2) with subsequent release of 
arachidonic acid. 
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PC12 cells 
 
PC12 cell characteristics 
 
Greene and Tischler (1976) first established PC12 cells from a transplantable rat 
adrenal pheochromocytoma.  Adrenal chromaffin cells and sympathetic neurons originate 
from a common neural crest stem cell.  This explains the fact that differentiated PC12 
cells preserve some neural characteristics such as presence of nicotinic-cholinergic and 
NGF receptors, synthesis and secretion of catecholamine, and expression of a number of 
neuropeptide genes (Margioris et al., 1992).  These features make this cell line an 
attractive in vitro model for studying differentiation of sympathetic neurons and other 
neuro-biochemical and -biological modifications such as apoptosis (Guroff, 1985).  PC12 
cells are round in shape and tend to grow in clusters.  They are small in diameter (6-
14µm) and slow in growing, which is reflected by their doubling time of 72- 92 hours 
(Greene and Tischler, 1976).  Like primary sympathetic neurons, PC12 cells adhere 
poorly to plastic tissue-culture dishes; therefore extracellular matrix proteins such as 
collagen and laminin are used as substrates to enhance anchorage (Greene and Tischler, 
1976; Fujita, 1989).  
 
Nerve growth factor signaling 
 
Nerve growth factor (NGF) belongs to the neurotrophin family involved in 
coordinating the nervous system (NS) development and maintaining neuronal function 
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(Hoyle, 2003).  In fact, NGF promotes the survival and maturation of neurons in both 
central and developing peripheral NS (Johnson and Yip, 1985; Belliveau et al., 1997; 
Glebova et al., 2004).  Like sympathetic neurons, PC12 cells differentiate in the presence 
of NGF and become dependent on the trophic factor for survival.  Once terminally 
differentiated, the rat pheochromocytoma cells undergo apoptosis following NGF 
withdrawal exhibiting similar biochemical characteristics of programmed cell death 
(PCD) (Lambeng et al., 1999; Vaghefi et al., 2004).  
Molecular studies have shown that NGF exerts its effect by binding to two 
distinct cell-surface receptors, tyrosine kinase A receptor (TrkA) and p75 NGF (Johnson et 
al., 1986; Kaplan et al., 1991).  P75 NGF is a 75 kDa transmembrane protein that binds 
NGF with low affinity and belongs to the tumor necrosis factor receptor family.  On the 
other hand, TrkA is a 140 kDa receptor that binds NGF with high affinity (Kaplan et al., 
1991).  NGF-induced survival is elicited through TrkA receptors, however in the absence 
of TrkA, p75 NGF acts as a neuronal death factor (Deshmukh and Johnson, 1997; 
Belliveau et al., 1997).  On the other hand, Barett and Barlett (1994) demonstrated that 
the p75 NGF activity is dependent on the neuronal stage of development.  It is required for 
NGF-mediated survival in neurons at the stage of target innervations but can mediate an 
apoptotic signal at a later stage of development (Bamji et al., 1998).  Thus, depending on 
the perinatal stage, p75 NGF alternates between function (Chao and Hempstead, 1995).  
However, other evidence points toward the sufficiency of NGF binding to TrkA to 
mediate sympathetic neuronal survival and growth.  Ligand-mediated activation of TrkA, 
but not p75 NGF, was able to maintain growth and survival of sympathetic neurons, which 
were lost in TrkA /  mice.  Nevertheless, in the absence of Trk receptors or under 
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conditions of nerve injury and stress, p75 NGF is frequently upregulated and capable of 
independent signaling (Kohn et al., 1999). 
Nerve growth factor withdrawal signaling 
NGF withdrawal from sympathetic neurons and terminally differentiated PC12 
cells elicits a biochemical cascade resulting in PCD activation (Edwards and Tolkovsky, 
1994; Lambeng et al., 1999; Vaghefi et al., 2004).  In fact, NGF deprivation is followed 
by an immediate TrkA dephosphorylation, which leads to oxidative stress burst (Kohn et 
al., 1998).  The sudden increase in oxygen species is believed to prompt an intracellular 
signaling, which activates MEKK, SEK, and JNK, through binding to the adaptor protein 
POSH (Tapon et al, 1998; Xu et al., 2003).  Consequently, stimulation of signaling 
molecules leads to induction of c-jun transcription factor with subsequent expression of 
pro-apoptotic Bim and Bax (Papadakis et al., 2006).  As a result, cytochrome C is 
released from the mitochondria and thecaspase cascade is activated (Slee et al., 1999).  
Chromatin condensation and DNA fragmentation are the final hallmarks of cell death 
(Lambeng et al. 1999; Gotz et al., 2000).  
 
Effects of NGF on PC12 cell differentiation 
 
As mentioned previously, the PC12 cell line is widely used as a model for 
studying sympathetic-like neuronal differentiation and other neuro-biochemical and -
biological modifications (Guroff, 1985).  The description by Greene and Tischler (1976) 
of PC12 cell differentiation involves cessation of proliferation and neurite outgrowth.  
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Treatment with nerve growth factor (NGF) (50ng/ml) for 7 days resulted in the 
termination of cell multiplication with concomitant neuronal-like processes outgrowth 
(Greene and Tischler, 1976). There are a number of morphological and chemical markers 
associated with NGF-induced differentiation of PC12 cells.  These include growth of 
neurite processes, enhancement of nicotine-stimulated dopamine release, increase in 
cAMP levels, and induction of certain proteins and neuropeptides (Margioris et al., 
1992).  
 However, PC12 cell response to NGF withdrawal was dependent on the degree of 
differentiation.  In differentiating cells, NGF withdrawal compromised the cell body 
integrity and causes loss of neurite extensions while cell division resumed within three 
days.  However, when replated in NGF-containing media, the cells regenerated processes 
within 24 hours (Greene and Tischler, 1976).  When terminally differentiated PC12 cells 
were NGF deprived, they lost their neurites and failed to regenerate their fibers as they 
fell short of re-entering the cell cycle and therefore underwent apoptosis (Lambeng et al., 
1999). The most rapid changes that occur following NGF addition were detected in the 
cell membrane and in the growth cones (Connolly et al., 1979; Seeley et al., 1983).  
Within seconds of NGF addition, the quantity of microvilli decreased and the number of 
coated pits increased (Connolly et al., 1979).  These sudden changes were only transient 
as the membrane returned to its normal appearance within seven minutes.  In addition, 
PC12 cell nuclei appear to mediate some of NGF activity.  In fact, following 
internalization of NGF a considerable portion of the trophic factor binds to its nuclear 
receptors (Yankner and Shooter, 1979). 
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NGF-induced signaling in PC12 cells 
 
PC12 cells have been the primary system used to study neurotrophin signaling in 
vitro (reviewed in Klesse et al., 1999).  The activation of TrkA receptors recruits 
molecules such as the three well characterized effectors PLCγ, Shc and 
phosphatidylinositol 3-kinase (PI3-K) (Fagan et al., 1996; Klesse et al., 1999).  PLCγ 
splits phophatidylinositol into DAG and IP3 and therefore activates Protein Kinase C 
(PKC).  PKC increases intracellular calcium ions which mediate cytoskeleton remodeling 
(reviewed in Klesse et al., 1999).  Shc activates Ras and downstream MAPK pathway 
including mitogen-activated protein kinase kinase (MEK) and extracellular signal-
regulated kinase (ERK) (reviewed in Klesse et al., 1999).  PI3-K stimulates Akt 
activation, which has been implicated in survival of different cell types (Datta et al., 
1997).  In addition, PI3-K effect through Ras/ERK pathway stimulation is essential 
and adequate signaling for NGF-induced survival in PC12 cells (reviewed in Klesse et 
al., 1999).  PI3-K also stimulates c-Jun NH2-terminal kinases (JNKs), which, through 
activation of c-Jun, support differentiation or apoptosis, depending on the differentiation 
status and NGF exposure of the cell.  Vaudry et al. (2002) proposed that the duration of 
Ras/ERK pathway signaling produces distinct outcomes, which include survival, 
proliferation, and differentiation of PC12 cells.  Rapid and transient Ras/ERK activation 
stimulates survival and proliferation whereas rapid but sustained activation induce 
differentiation of PC12 cells.  The three integrated processes represent obviously a 
balance between MAPK signaling pathways that depends on the concentration of 
neurotrophins and the type of first messengers in close proximity (Vaudry et al., 2002). 
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Effects of AT2 receptor and NGF on PC12 cell differentiation and apoptosis 
 
The high expression of AT2 receptor during fetal and neonatal development has 
suggested the implication of this receptor in tissue growth and/or differentiation 
(Nakajima et al., 1995).  In vitro, there is a restricted number of primary cell cultures and 
cell lines that express AT2 receptors in culture, usually only under certain culture 
conditions ( reviewed in de Gasparo et al., 2000).  PC12 cells and the subclone PC12W 
are among the cell lines that express AT2 receptors (reviewed in de Gasparo et al., 2000; 
Wolf et al., 2002).  In PC12W cells, stimulation of AT2 receptor via angiotensin II led to 
cell differentiation and enhanced neurite outgrowth by increasing polymerization of 
microtubules (Stroth et al., 1998).  When compared to the differentiation effect of NGF 
on PC12W cells, AT2 receptors were found to have a differential upregulation of 
microtubule-associated proteins (MAP).  While NGF increased expression of β-tubulin, 
MAP1 and MAP2, angiotensin II increased polymerization of β-tubulin but down-
regulated MAP1 protein levels in naïve and differentiated PC12W cells.  In addition, 
AT2 receptor antagonist PD123177, but not AT1 receptor antagonist losartan, abolished 
all the above-mentioned effects of angiotensin II (Stroth et al., 1998).  These findings 
suggest that AT2 receptors play a critical role in cell differentiation via regulation of the 
cytoskeleton.          
 Consequently, AT2 and NGF receptors induce differentiation via differential 
cytoskeleton reorganization (Stroth et al., 1998).  One possible mechanism for this 
disparity is the activation of phosphatases by AT2 receptors.  Growth factors mediate 
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their growth promoting actions via TrK receptors and downstream kinase-driven 
phosphorylation.  Extracellular signal-regulated kinases 1 and 2 (ERK 1/2) and mitogen 
activated protein kinases (MAPK) appear to play a key role in these phosphorylation 
cascades (Nakajima et al., 1995; Yamada et al., 1996).  Angiotensin II via AT2 receptor 
transiently increases ERK phosphorylation; however its action is reversed through 
phosphatase activation (Steckelings et al., 2005). Conversely, angiotensin II-dependent 
and –independent AT2 receptor activation has been linked to PC12W cell apoptosis 
(Yamada et al., 1996; Miura et al., 2000).  In fact, apoptosis was shown to occur through 
ERK inactivation by two separate phosphatases: MAPK phosphatase-1(MKP-1), which 
dephosphorylates Bcl-2 and SH2 domain-containing phosphatase-1 (SHP-1) (Horiuchi et 
al., 1997; Lehtonen et al., 1999).   
Taken together, this suggests that NADPH oxidase may be involved in PC12 cell 
differentiation and apoptosis by possible differential production of ROS. In addition, 
angiotensin II, the activator of the enzyme, may increase both processes through 
activation of AT2 receptors. 
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Chapter II 
NADPH oxidase expression in PC12 cell 
differentiation 
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Abstract    
 
PC12 cells differentiate into sympathetic-like neurons in the presence of 
nerve growth factor (NGF). The trigger for this process is a burst of reactive 
oxygen species (ROS) that is necessary but not sufficient for this phenomenon. A 
wealth of data points to the mitochondria as the major source of ROS, however 
new data suggest that the non-mitochondrial enzyme NADPH oxidase may be 
directly involved in this process. However, the identity of the subunits involved in 
PC12 cell differentiation has not been established.  We report that co-incubation 
of NGF and angiotensin II (NADPH oxidase activator) produces a more 
pronounced burst of ROS and accelerates the rate of PC12 cell differentiation in 
comparison to NGF alone.  In this study, we measured cellular ROS generation in 
the presence of different pharmacological agents.  Cellular differentiation and 
ROS production significantly decreased upon addition of DPI (an NADPH 
oxidase inhibitor) or PD123177 (angiotensin II- type 2 receptor inhibitor).  Using 
western blot analysis, we demonstrated that the addition of NGF increases Nox1, 
Nox4, and p47-phox levels.  Concurrent administration of NGF and angiotensin II 
produced a similar increase with an earlier synthesis of those subunits.  Taken 
together, NADPH oxidase appears to be involved in PC12 cell differentiation 
following NGF treatment. 
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Introduction 
 
Neuronal differentiation during development 
 
Neurons are generated from repeated divisions of progenitor cells during 
embryogenesis (Gotlieb, 2002).  In addition, neuritogenesis is a vital process that 
accompanies neuronal growth.  It includes three major phases: neurite protrusion, 
elongation, and network formation (Sebok et al., 1999; Lindwall et al., 2007).  The 
premature neuron begins as a flat, perisomatic lamellipodium before short neurites 
emerge.  At this early point of development, the early neurites are identical in 
morphology and molecular composition.  One set of neurites becomes axons, while 
others develop into dendrites (Arimura and Kaibuchi, 2005; Jiang et al., 2005; Wiggin et 
al., 2005).  Axons find their targets through long- and short-range guidance cues and 
chemoattractants (Mueller, 1999; Liu and Snider, 2001; Lindwall et al., 2007).  Once at 
the target, axons conclude their maturation process by a series of events including the 
formation of terminal branches and synapses.   Further, as neurons develop they exhibit 
an increase in neurite thickness and in cell-body size, both of which are controlled at 
transcriptional and translational levels (Meinertzhagen, 1994; Stocker and Hafen, 2000).   
 
NADPH oxidase in cellular differentiation 
 
While the majority of published reports focus on the role of ROS in 
neurodegeneration, oxidative intermediates may also function as essential mediators of 
cellular differentiation (Su et al., 2001; Suzukawa et al., 2000).  In fact, sub-toxic 
amounts of ROS are able to act as intracellular second messengers by activating signaling 
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cascades involved in growth and differentiation in several cell types (reviewed in Rhee, 
1999; Laloi et al., 2004).  In vivo, neuronal differentiation is regulated by the action of 
growth factors such as NGF (Barde, 1989).  In vitro, NGF stimulates growth arrest and 
induces neurite development in PC12 cells (Barde, 1989), and recent reports link the 
generation of ROS to NGF-mediated neurite outgrowth in these cells (Suzukawa et al., 
2000; Ibi et al., 2006).  Independent use of N-acetylcysteine (an antioxidant) and of 
diphenylene iodonium (a flavoprotein antagonist) abolished the increase in ROS 
production with concomitant inhibition of NGF-induced neurite outgrowth.  This 
suggests that ROS-stimulated PC12 cell differentiation occurs through the regulation of a 
flavin-containing enzyme similar to NADPH oxidase (Suzukawa et al., 2000).  NADPH 
oxidase is necessary for cellular differentiation of various tissues through redox signaling 
(Suzukawa et al., 2000; Geiszt et al., 2003). Nox4, a catalytic subunit of NADPH 
oxidase, is involved in cellular differentiation of cardiac, vascular smooth muscle and 
renal cells (Wolf, 2005; Griendling, 2006; Li et al., 2006).  Despite these latest reports, 
the precise mechanisms involving ROS, and specifically the role of NADPH oxidase, in 
neuronal differentiation requires further investigation. 
 
Effect of angiotensin II-induced AT2 receptor activation on cellular differentiation 
 
Angiotensin II type 2 receptor (AT2) has been found to be directly involved in 
growth control and cell differentiation in many cell types (Millan et al., 1991; Nakajima 
et al., 1995).  Indeed, the activation of AT2 receptors has been linked to growth arrest and 
cell differentiation in PC12W cells (Meffert et al., 1996; Gallinat et al., 1997; Stroth et 
al., 1998).  In fact, stimulation of AT2 receptors via angiotensin II led to PC12W cell 
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differentiation and enhanced neurite outgrowth by increasing microtubule 
polymerization.  When compared to the effect of NGF through TrkA activation, AT2 
receptors produced a differential upregulation of microtubule-associated proteins (MAP) 
(Gallinat et al., 1997).  MAP1 increases axonal stability and MAP2 induces dendritic 
maturation.  NGF increased protein levels of MAP1 whereas angiotensin II down-
regulated MAP1 protein levels in naïve and differentiated PC12W cells (Gallinat et al., 
1997).  Administration of PD123177, an AT2 receptor antagonist, reversed the observed 
angiotensin II effects (Stroth et al., 1998).  All together, this is suggestive that angiotensin 
II acts through AT2 receptors to modulate the cytoskeleton.  In addition, distinct 
intracellular pathways are involved in NGF- and angiotensin II-induced regulation of the 
cytoskeletal proteins, as AT2 receptor activation resulted in a transient increase in ERK 
activity (Stroth et al., 2000). We hypothesized that NADPH oxidase is involved in PC12 
cell differentiation, which might be linked to an early burst of ROS production. In 
addition, angiotensin II as the enzyme activator may increase or speed-up the process.  
Here we report that the combination of NGF and angiotensin II results in earlier 
and more pronounced ROS than is observed after adding NGF alone, suggesting NADPH 
oxidase may be important in this process.  Western blot analysis indicates that NGF 
treatment alone increases the levels of specific NADPH oxidase subunits, and the 
addition of angiotensin II with NGF results in an earlier protein synthesis of NADPH 
oxidase subunits. Overall, these results confirm and extend our hypothesis that NADPH 
oxidase is involved in PC12 cell differentiation.  
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Materials and Methods 
 
 
 
 
PC12 cell culture 
 
Rat pheochromocytoma (PC12) cells were obtained from the American Type 
Culture Collection (ATCC, Manassas, VA) at an unknown passage.  Cultures were 
maintained at 37°C, 5% CO2 / 95% air in Ham's F-12K growth media supplemented with 
2 mM L-glutamine 15% horse serum; 2.5% fetal bovine serum (Cellgro, Herndon, VA).  
Cultures were grown in collagen-treated 10-cm culture dishes with media exchange every 
other day (Falcon, San Jose, CA).  For experimental purposes, 6-well, 24-well, or 96-well 
tissue were used (Falcon). For expression studies, the cells were treated with NGF (50 
ng/ml) as was suggested by Greene and Tischler (1976) or NGF (50 ng/ml) + angiotensin 
II (10 µM) (NGF/AngII) (Yamada et al., 1996) for different experimental time points (2, 
4, 6, 8, 18, 24 and 48h).    
 
Cell passage  
 
Cells were analyzed before passaging using a light microscope (Carl Zeiss 
MicroImaging, Inc., Thornwood, New York).  Old media was removed by power suction 
followed by addition of 2 ul of trypsin/EDTA (Sigma). The cells were incubated at 37°C 
for 5 minutes. To stop the proteolytic action of trypsin, 3 ml of culture media was added 
and cells were dispersed by repeated forceful pipetting.  The suspension was transferred 
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into a 50-ml BD Falcon Conical tube and the cells were centrifuged at 400 x g for 10 
minutes.  The supernatant was discarded and the cells were resuspended in fresh medium.  
Differentiation Cell Count 
 PC12 cells were seeded as single cells at a concentration of 0.5 x 104 cell/well.  
Twenty-four hours after seeding, the old media was removed and fresh experimental 
media was added. The experimental groups included: NGF (50 ng/ml), NGF  (50 ng/ml) 
+ angiotensin II (10 µM) (NGF/AngII), NGF  (50 ng/ml) + angiotensin II (10 µM)  + 
PD123177 (1 µM) (NGF/AngII /PD), NGF  (50 ng/ml) + angiotensin II (10 µM) + DPI (5 
µM) (NGF/AngII /DPI), or NGF  (50 ng/ml)  + PD123177  (1 µM) (N/PD).  The 
frequency of cells manifesting differentiating morphology (neurites) was scored by an 
observer “blinded” as to the experimental treatment.  Each condition was evaluated at 
least three times. 
 
Oxidative stress analysis  
 
 
2’, 7’-dichlorofluorescein diacetate (DCFHDA) assay is a widely used method for 
measuring intracellular reactive oxygen species (ROS).  DCFHDA is converted to DCFH 
by cleavage of its ester bond by means of intracellular esterases.  Non-fluorescent DCFH 
is oxidized to DCF (fluorescent dichlorofluorescein) in the presence of H2O2, which is the 
immediate byproduct of ROS.  Thus, it is a valuable tool to measure intracellular ROS 
generation.  PC12 cells were cultured onto collagen-treated 96-well plates at a 
concentration of 3 x 103 cell/well.  The control groups comprised cells cultured in the 
presence of F-12K, NGF and angiotensin II.  Experimental groups included the addition 
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of NGF + angiotensin II (N/A), NGF + DPI (5 µM) (N/DPI), NGF+ angiotensin II + 
PD123177 (N/A/PD), NGF+ angiotensin II + DPI (5 µM) (N/A/DPI).  The cells were 
treated with different treatments at different time points and preloaded with DCFHDA in 
DMSO (5 µg/ml, Molecular Probes) for 30 minutes at 37 oC.  All DCFHDA solutions 
were prepared fresh instantly before the assay.  A multi-channel pipette was used to 
supply 100 µl/well.  The DCF fluorescence was measured using a CytoFluor II 
Fluorescence Plate reader (Applied Biosystems, Foster City, CA) with an excitation 
wavelength of 485/20 nm and an emission wavelength of 530/35 nm.  
 
RNA isolation procedure 
PC12 cells were seeded at a concentration of 0.25 x 106 cells/well onto 24-well 
plates.  Each experimental group comprised four wells.  RNA extraction was carried out 
following the manufacturer's protocol. Briefly, RNA was isolated using 250 µl of Trizol® 
reagent (Gibco Invitrogen, Carlsbad, CA, USA) per well, incubated at room temperature 
for 10 min, and collected in RNAse-free 1.5 ml Eppendorf tubes.  Chloroform (1/5 
volume) was added per 1ml of Trizol®-cell solution. The tubes were manually inverted 
and allowed to incubate for 5 minutes at room temperature.  This was followed by 
centrifugation at 4°C at 7558 x g for 5 min. The aqueous phase, which contains RNA, 
was transferred into separate 1.5 ml Eppendorf tubes (Westbury, NY). Isopropyl alcohol 
(100%) 1/2 volume was added and the sample was left for 10 minutes at room 
temperature.  Another cold centrifugation at 7558 x g for 15 minutes forms the RNA the 
pellet, which was washed with 250 µl of 75% ethanol and cold centrifuged at 2516 x g 
for 5 minutes.  The ethanol was removed by careful pipetting to avoid disruption of the 
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precipitated RNA, and the pellet was allowed to dry for 10 min at room temperature and 
resuspended in RNAse-free DEPC water (0.1%). Quantification of the RNA was 
performed by measuring optical density at 260 nm using a spectrophotometer. RNA 
samples were kept frozen at -80 °C until used. 
 
Reverse Transcription Reaction  
 
Five µg of total RNA was mixed with oligo (dT) primers (50mM) and 10mM 
dNTP in PCR tubes.  The combination was heated at 70°C for 5 minutes and immediately 
placed on ice for 2 minutes.  A stock solution of the following was prepared: 6 µl 5 x 
reverse transcription buffer, 1 µl of RNAseOut® (40 U/µl), 1 µl of SuperScript RT III 
(200 U/µl) and 1 µl DTT (0.1M).  Negative controls were prepared with no addition of 
RT to detect any DNA contamination.  Gentle pipetting and a quick spin were performed 
to collect the content.  The stock solution was added to the RNA/oligo (dT) mixture and 
incubated at 50°C for 50 minutes.  The reaction was inactivated at 85°C for 5 minutes.  
To destroy the RNA template, 1 µl of RNAse H was added to the mixture and followed 
by incubation at 37°C for 20 minutes.  The cDNA mixture was stored at -20°C until use 
for polymerase chain reaction.  
 
Polymerase Chain Reaction (PCR) 
 
Platinum® Taq DNA Polymerase (Sigma, St. Louis, MO) is a recombinant DNA 
polymerase attached to an inhibitory antibody to prevent unnecessary activity at ambient 
temperatures.  Heating the complex to 94°C causes the denaturation of the antibody and 
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subsequent activation of the Platinum® Taq DNA Polymerase.  The mixture provides the 
free nucleotides needed for the elongation of the product.  All reagents were mixed and 
centrifuged briefly before addition and were kept on ice.  The reaction mixture was 
prepared in 0.5 ml RNAse-free PCR tubes as follows: 2.0 unit of Taq Polymerase, 0.6 µl  
(5pmole) of each primer (+/-), and 5 µg of template in 15 µl reaction . The reaction mix 
was briefly centrifuged to ensure homogeneous blending.  All PCR reactions were 
performed using a PCRexpress thermocycler ® (Hybaid Omnigene Thermocycler, UK).  
Briefly, the mixture was heated to 94°C for 2 minutes to activate Taq polymerase known 
as the “hot start” and denature the DNA.  The first step was followed by an annealing for 
30 seconds (the temperature used depended on the primer utilized) and an extension step 
at 72°C for 30 sec- 1 minute depending on the size of the target product.  The annealing 
temperatures were optimized by doing a temperature gradient PCR starting 5°C below 
the calculated Tm going up to 12°C until the most stringent conditions were found.  
Subsequent cycling heated the mix at 94°C for only 30 seconds.  The cycle of melting, 
annealing, and extending was repeated between 25-30 times determined by cycle 
bracketing.  Final extension was at 72°C for 10 minutes. All primers were generated at 
Integrated DNA Technology (Coralville, IA) and are listed in Table 1. 
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Table 1. Primer sequences used in the differentiation study 
 
Primer Sequence 
nox1 sense 5’-AACCACACGCTGAGACCATTCGA-3’ 
nox1 antisense 5’-TCAGCTAAGGCAGGTTTCCCAGA-3’ 
nox4 sense 5’-AGGTGTCTGCATGGTGGTGGTATT-3 
nox4 antisense 5’-AAAGAGGGCTGTGGCTATCAGCTT-3’ 
p47-phox sense 5’-CAGCCAGCACTATGTGTACAT-3’ 
p47-phox antisense 5’-GAACTCGTAGATATAGGTGAA-3’ 
p67-phox sense 5’-GGGAACCAGCTGATAGACTACAT-3’ 
p67-phox antisense 5’-TCCATTCCTCTTTCTTGGCAATT-3’ 
NSE sense 5’-ACGCTGGACTCGCTGGGCAA-3’ 
NSE antisense 5’-GCGAGCGCGCTGCGCTTGTA-3’ 
 
 
DNA gel electrophoresis 
 
PCR products were separated on 1-2% agarose gels in 1X TAE (0.04 M Tris-
Acetate, 0.002 M EDTA, pH 8.0).  The electrophoresis apparatus was set at 100 V for 45 
min and 0.5 x SYBER Gold (Molecular Probes, Eugene, OR) stained the gel for at least 
30 minutes.  The PCR products were visualized under ultraviolet light. 
 
DNA sequencing 
 
 Identification of PCR products was confirmed by direct DNA sequencing.  cDNA 
sequencing was performed using DYEnamic ET terminator Cycle Sequencing kit® 
 (GE Healthcare, formerly Amersham Bioscience, Piscataway, NJ) according to the 
manufacturer protocol using ABI Prism® 310 genetic analyzer (PE Applied Biosystems, 
PE Applied Biosystems, Foster City,. CA). 
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Protein extraction procedure 
 
In order to obtain samples for western blot analysis, PC12 cells were seeded at a 
concentration of 0.25 x 106 cells/well onto 24-well plates.  Each experimental group 
comprised four wells.  Protein extraction was carried out on ice to prevent further protein 
modification.  Cells were washed with cold sterile phosphate-buffer saline (PBS) (500 
µl/well) to remove traces of proteins from the media.  Cell lysates were collected in lysis 
buffer (1 X 10mM Tris-HCl, 1mM EDTA, pH 7.4) + Protease Inhibitor Cocktail (PIC) 
(Roche, Mannheim, Germany) + 0.1 % Triton X+ phosphatase inhibitor).  PIC contains a 
mixture of proteases that inhibit serine, cysteine, and metalloprotease activity.  The 
composition of the PIC is as follows:  Chymotrypsin, 1.5 µg/ml, Thermolysin, 0.8 µg/ml, 
Papain, 1 mg/ml, Pronase, 1.5 µg/ml, Pancreatic extract, 1.5 µg/ml, Trypsin, 0.002 µg/ml.  
Samples were sonicated for cell disruption and centrifuged at 4° C 7558 x g for 10 
minutes. The supernatant containing the protein extract was collected and stored at -80°C 
until further analysis. 
Western Blot analysis 
 
Protein concentrations were quantified using serial dilutions of BSA as standards 
for Bradford protein assay (Bio-Rad, Hercules, CA).  The BSA solution was added in 
increments of 2µg and assayed in triplicate.  Equal amounts of protein were boiled in 
SDS electrophoresis buffer (containing 2-mercaptoethanol) at 90oC for 10 minutes.  
Protein separation was performed by a 12% SDS-PAGE using Xcell SureLock® 
(Invitrogen).  The proteins were transferred to a polyvinylidene fluoride (PVDF) 
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microporous membrane (Millipore Immobion-P #IPVH 000 10, St. Louis, MO) pre-
soaked in 100% methanol and transfer buffer ( 200mM glycine, 25mM Tris, 20% 
methanol) .  Transfer of the blot onto the membrane was performed using Xcell II Blot 
Module® (Invitrogen).  The blot was blocked with 5% non-fat milk in Tris-Buffered 
Saline (27mM Tris, 57 mM NaCl, pH 7.5) for 1 hour at room temperature.  The primary 
antibody was diluted at a concentration of 1:800 in blocking solution and incubated for 
60 minutes at room temperature on a rocker.  The following antibodies were used in this 
study: anti-Nox1 (cat. 25545, Santa Cruz Biotechnology, Inc., Santa Cruz, CA), anti-
Nox4 (cat. 5514, Santa Cruz), anti-α-tubulin (cat. 2144, Cell Signaling Technology, Inc., 
Danvers, MA), anti-p47-phox and anti-p67-phox were a generous gift from Dr. Mark 
Quinn (Montana State University).  The membrane was washed three times with 1xTBS, 
0.05% Tween 20).  A horseradish peroxidase (HRP)-conjugated secondary antibody 
(cat.7074, Cell Signaling Technology, Inc.) diluted in TBS-t (1:1000) was added for 45 
minutes.  Amersham ECL kit (RPN 2106) (GE healthcare, Piscataway, NJ) was prepared 
following the manufacturer protocol. Band detection was achieved using Kodak X-Ray 
film (Eastman Kodak, Rochester, NY) and quantified by QuantOne (BioRad). 
Statistics 
 
The results are expressed as the mean + SEM of three or more independent 
experiments.  Significant differences in measured values were evaluated with an analysis 
of a Student’s t-test or ANOVA.  Statistical significance was set at p < 0.05.  Statistical 
analysis and graphing were performed using Microsoft Excel.  
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Results 
Differentiation of PC12 cells in response to different treatments 
 
 
Since PC12 cells differentiate in the presence of nerve growth factor, NGF-treated 
cells were used as a control group in this experiment (Greene and Tischler, 1976).  
NGF/AngII treatment significantly increased the percentage of differentiated cells up to 
day 4 after NGF addition after which NGF-treated PC12 cells became statistically 
comparable (Fig. 2).  In contrast, DPI- and PD123177- treated cells generated a 
significant delay in differentiation when compared to the averaged values from cells 
treated with NGF alone.  However, DPI-treated cells showed the slowest rate of 
differentiation among all as both DPI groups lagged behind other treatments, suggesting 
that DPI significantly delays but does not block differentiation (Fig. 2). 
Qualitative observations revealed that NGF/AngII-treated PC12 cells had longer 
and neurite extensions as soon as day 3 post-treatment (data not shown) and more neurite 
branching when compared to cells treated with NGF alone on day 7 (Fig. 3).  DPI-treated 
cells exhibited a lesser degree of differentiation (Fig. 3).  Interestingly, the size of the 
DPI-treated cell body appeared comparable to the NGF-treated group on day 7 and day 8, 
however the network of neurite outgrowth was poorly developed as no branching of 
neurites was observed (Fig. 3).  In contrast, PD123177 slowed down the differentiation 
process without affecting the morphology of the neurites.  In fact, differentiated 
PD123177-treated cells developed a neurite meshwork similar to that detected in NGF-
counterparts but fewer cells differentiated. 
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Co-administration of NGF and angiotensin II produces an earlier and higher burst 
of ROS 
 
Previous investigators revealed that NGF-dependent neurite outgrowth in PC12 
cells is subsequent to a transient increase in ROS concentration peaking at 10 minutes 
following NGF addition.  The same group suggested that ROS acts as an intracellular 
signal mediator for NGF-induced neuronal differentiation (Suzukawa et al., 2000).  Our 
finding regarding NGF/AngII accelerating differentiation of PC12 cells prompted us to 
examine the effect of this particular combination on ROS production.  We hypothesized 
that this increase in the rate of PC12 cell differentiation was due to an earlier and/or 
higher level of ROS production. NGF addition produced a peak of ROS at 10 minutes 
followed by a gradual decrease to basal levels by 60 minutes confirming previous reports.  
On the other hand, NGF/AngII addition created significantly higher values when 
compared to NGF administration alone up to 20 minutes post-treatment, supporting our 
theory (Fig. 4).  Interestingly, NGF/AngII at 5 minutes produced statistically similar 
values to those of NGF at 10 minutes.  These data suggest that an earlier and a higher 
burst of ROS may play a role in the accelerated rate of PC12 cell differentiation. 
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Figure 2.  Differentiation of PC12 cells for 8 days using different pharmacological 
treatments.  Differentiated cells were defined as cells with protruding processes 
regardless of size.  Counting was blinded and performed three times to account for any 
preconceived conclusion.  NGF, N/A= NGF + angiotensin II, N/A/PD = NGF + 
angiotensin II + PD123177, N/A/DPI = NGF + angiotensin II + DPI, N/DPI = NGF+ 
DPI; N/PD = NGF + PD1231 77. Each bar represents the average of three independent 
readings. The asterisk represents significant difference from the control (NGF) at each 
timepoint. The data represent the mean + SEM of three blinded and independent cell 
counting (p<0.05). 
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 NGF-7days                                                  NGF/Ag II- 7days 
 
 
 
 
 
 
 
 
 
Figure 3. PC12 differentiation in the presence of NGF, NGF/AngII and NGF/DPI  
DPI on day 7. N/A-treated PC12 cells showed a higher degree of differentiation, larger 
cell body and more elaborate neurite network. The DPI-treated PC12 cells lack the mesh 
of network detected in the NGF and N/A treated PC12 cells. 
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Figure 4.  NGF/AngII produces an earlier and more pronounced burst of ROS 
compared to NGF treatment. PC12 cells were seeded as described in Materials and 
Methods. Twenty-four hours after seeding, PC12 cells were treated with either NGF (50 
ng/ml) or N/A (NGF + angiotensin II (10 µM) at different experimental time points 
starting 75 minutes before fluorescence reading.  The DCFHDA was preloaded for 30 
minutes prior to fluorescence quantification. Relative DCF fluorescence intensity shown 
is from triplicate experiments. The asterisk denotes significant difference between both 
experimental groups (p <0.05). 
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ROS production varies in response to NGF, angiotensin II, PDI and PD123177 
treatments 
 
Since NADPH oxidase inhibitor DPI significantly delayed NGF-mediated 
differentiation in PC12 cells, we examined the effect of this compound on ROS 
production following NGF addition. Enhanced generation of ROS was observed in the 
first 20 minutes of NGF/AngII exposure as compared to NGF or angiotensin II alone 
(Fig. 5) suggesting  that the trophic factor and NADPH oxidase activator exhibit a 
synergistic activity on ROS production.  PD123177 or DPI (5 µM) concurrent 
administration with NGF/AngII significantly decreased DCF fluorescence compared to 
the NGF/AngII values. In addition, the fact that AT2- antagonist, PD123177, 
significantly reduced ROS production when administered with NGF/AngII suggests that 
angiotensin II may act through AT2 receptor stimulation to generate ROS. DPI (1 µM), 
(5 µM) or PD123177 produced basal levels of DCF fluorescence. In addition, concurrent 
addition of DPI (1 µM) and NGF did not significantly decrease ROS production when 
compared to NGF values (data not shown). DCF readings were carried up to 8h post-
treatment; however no significant differences were detected among the experimental 
groups beyond 20 minutes of treatment administration. 
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Figure 5.  Effects of different treatments on ROS production in PC12 cells. (A)To 
examine the effect of angiotensin II, DPI and PD123177 on intracellular ROS production, 
thirteen 96-well plates were seeded as previously described. The control groups 
comprised cells cultured in the presence of F-12K, NGF and angiotensin II.  
Experimental groups included the addition of NGF + angiotensin II (N/A), NGF + 
PD123177(N/PD), NGF + angiotensin II +PD123177 , (N/A/PD), NGF + DPI (N/DPI), 
NGF + angiotensin II + DPI (N/A/DPI).  Treatment started starting 60 minutes before 
fluorescence reading.  The DCFHDA was preloaded for 30 minutes prior to fluorescence 
quantification. ROS generation was detected by DCF fluorescence using CytoFluor II 
plate reader. The data represent the mean of three independent DCF measurements. (B) 
Graphical representation of the 10-minute time point. (* P < 0.05 significance from NGF 
treatment). 
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Expression of NADPH oxidase subunits in PC12 cells following short-term NGF and 
NGF/AngII addition. 
 
Previous data from our laboratory pointed toward the presence of NADPH 
oxidase in sympathetic neurons and PC12 cells (Tammariello et al., 2000; Hilburger et 
al., 2005).  We theorized that NADPH oxidase is a source of the ROS-mediated PC12 
differentiation.  We next looked at the transcript and protein levels of NADPH oxidase 
subunits following NGF addition to determine which subunits are putatively involved in 
differentiation of PC12 cells.  No changes were detected at the level of transcription 
following NGF addition alone except for p47-phox which was downregulated 4 hours 
post-treatment (Fig 6A). On the other hand, addition of NGF + angiotensin II resulted in 
nox4  upregulation (approximately two-fold increase) by 2h post-treatment, and nox1 and 
p47-phox by 4h following NGF/angII addition (Fig 6B). At the protein level Nox1 and 
p47-phox proteins were almost undetectable and were not altered by the addition of NGF. 
Nox4 and p67-phox protein levels remained constantly high regardless of differentiation 
status (Fig. 7A).  However, the addition of AngII coincident with NGF caused a 
significant proportional increase in the protein levels of Nox1 and p47-phox, and to a 
lesser extent Nox4 (Fig. 7B). 
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Figure 6.  RT-PCR analysis of NADPH oxidase subunit expression following NGF 
and NGF/AngII treatments with corresponding densitometry analysis.  PC12 cells 
were cultured as described in Material and Methods. Twenty-four hours after seeding, the 
cells were kept in regular F-12 K media (C, control) or treated with either NGF-
supplemented F-12K (50 ng/ml) (A) or NGF (50 ng/ml) and angiotensin II (10 µM) 
(NGF/AngII) (B) for 2 and 4 hours (+2h, +4h, respectively). Equal loading control is 
Neuron Specific Enolase (NSE). Densitometry values are means of three to four gels (* p 
< 0.05). 
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Figure 7.  Western blot analysis of NADPH oxidase subunit synthesis following NGF 
and NGF/AngII treatments with corresponding densitometry.  PC12 cells were 
cultured as described in Material and Methods. Twenty-four hours after seeding, the cells 
were kept in regular F-12 K media (C, control) or treated with either NGF-supplemented 
F-12K (50 ng/ml) (A) or NGF (50 ng/ml) and angiotensin II (10 uM) (NGF/AngII) (B)  
for 2 and 4 hours (+2h, +4h, respectively).  Equal loading control is α-tubulin. 
Densitometry values are means of three independent experiments (* p < 0.05). 
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Effects of long-term NGF and NGF/AngII addition on NADPH oxidase subunit 
synthesis  
 
While differences at the mRNA and protein levels were minimal at early time 
points after the addition of NGF, other investigators have reported that Nox1 levels 
increase significantly at the protein level in PC12 cells 72 hours following NGF addition 
(Ibi et al., 2006).  We therefore studied time-points between two and 48 hours after NGF 
addition in order to examine mRNA and protein profiles of the NADPH oxidase subunits.  
The addition of NGF did not alter the expression of the subunits except for the 
aforementioned decrease in p47-phox at four hours post-treatment. By eight hours post-
NGF administration the p47-phox transcript levels were re-established and significantly 
increased between 18 and 48 hours after NGF addition (Fig. 8A). When NGF and 
angiotensin II were administered concomitantly, nox1, nox4 and p47-phox transcripts 
were significantly increased by the 6h time-point and remained high for the duration of 
the experiment (Fig. 8B). At the protein level Nox1, Nox4 and p47-phox exhibited 
significant increases by eight hours following NGF addition (Fig. 9A).  Interestingly, the 
addition of angiotensin II concurrent with NGF led to the increase of these subunits at the 
protein level by six hours after NGF/AngII addition (Fig. 9B). 
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Figure 8.  RT-PCR analysis of NADPH oxidase subunit expression following long-
term addition of NGF and NGF/AngII treatments and corresponding densitometry.  
PC12 cells were cultured as described in Material and Methods. Twenty-four hours after 
seeding, the cells were either kept in regular F-12 K media (C, control) or treated with 
either NGF-supplemented F-12K (50 ng/ml) (A) or NGF (50 ng/ml) and angiotensin II 
(10 uM) (NGF/AngII) (B)  for 6, 8, 18, 24, and 48 hours.  Neuron Specific Enolase 
(NSE) is a loading control. Three independent experiments were carried out (* p < 0.05). 
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Figure 9.  Western blot analysis of  NADPH oxidase subunit synthesis following 
long-term addition of NGF and NGF/AngII treatments with corresponding 
densitometry.  PC12 cells were cultured as described in Material and Methods. Twenty-
four hours after seeding, the cells were kept in regular F-12 K media (C, control) or 
treated with either NGF-supplemented F-12K (50 ng/ml) (A) or NGF (50 ng/ml) and 
angiotensin II (10 uM) (NGF/AngII) (B)  for 6, 8, 18, 24, and 48 hours. Densitometry 
values are means of three independent experiments (* p < 0.05). 
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Discussion      
 
Rate of PC12 cells differentiation varies with different physiological and 
pharmacological treatments 
 
Various pharmacological agents have the ability to alter the differentiation process in 
eukaryotic cells by influencing the level of ROS production (Wolf, 2005).  Therefore, by 
using NADPH oxidase activator (angiotensin II) and inhibitor (DPI) we examined ROS 
production during PC12 cell differentiation. Diphenylene iodonium (DPI) inhibits 
activity of NADPH oxidase through direct addition of a phenyl group to the flavin 
molecule (Pullar and Hampton, 2002). Angiotensin II acts through AT2 receptors to 
induce cellular differentiation (Meffert et al., 1996). Therefore, PD123177 was used to 
limit AT2 receptor signaling involved in this process. The results of our study provide 
insight into the synergism of NGF and angiotensin II as illustrated by enhanced PC12 cell 
differentiation.  However, their molecular mechanisms were reported to be dissimilar 
when it comes to cytoskeletal rearrangement (Gallinat et al., 1997).  According to Stroth 
et al. (1998), NGF treatment of PC12W cells increased synthesis of cytoskeletal proteins 
involved in axonal stability such as MAP1, whereas angiotensin II increases levels of 
MAP2 proteins needed for dendritic maturation.  Nevertheless, both treatments were 
reported to stimulate microtubule polymerization.  This suggests that axons and dendrites 
are formed and stabilized simultaneously, which could substantiate in part that 
NGF/AngII-treated cells differentiated faster and produced a more extensive neurite 
network. Compared to the NGF/AngII group, the NGF/AngII /PD showed a significant 
reduction in the number of differentiated PC12 cells.  However, the morphology of these 
cells detected on day 7 and day 8 exhibited phenotypic characteristics of a mature neuron; 
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however only a few cells were differentiated compared to the NGF-treated group. This 
does not fully agree with a published report stating that PD123177 completely abolished 
angiotensin II-enhanced differentiation of PC12W cells (Stroth et al., 1998).  However, 
the discrepancy probably lies in the concentration of angiotensin II and PD123177 
administered.  While we used 10 µM of angiotensin II and 1 µM of PD123177, these 
investigators used 0.1 µM and 10 µM, respectively.  Another divergence was noted in the 
days of differentiation.  While we carried out PC12 differentiation up to eight days, their 
study only looked at molecular changes up to day 4.  According to our results, 
NGF/AngII /PD123177 produced little differentiation by day 4, but neurite growth was 
observed by day 5. 
  DPI-treated cells exhibited a reduced neurite outgrowth confirming previous 
published reports (Suzukawa et al., 2000). Surprisingly, the cell body size of DPI-treated 
cells exhibited a morphology similar to the one detected in NGF-treated cells on day 7 
and day 8 post-treatment, suggesting that PC12 cell differentiation involves cross-talk 
between two or more signaling pathways.  
 
The rate and amount of ROS produced corresponded to the degree of PC12 cell 
differentiation 
 
 We examined ROS production in PC12 cells following NGF and NGF/AngII 
addition.  NGF administration produced a peak of ROS at 10 min post-treatment, which 
corroborated other reports (Suzukawa et al., 2000; Ibi et al., 2006).  This ROS burst is 
necessary to trigger differentiation in PC12 cells (Suzukawa et al., 2000). The increase in 
ROS and the higher degree of differentiation observed following NGF/AngII treatment 
may explain in part the fact that neurons produce an elaborate network of axons and 
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dendrites through altering the kinetics of the signaling pathways involved (Vaudry et al., 
2002). In fact, developing neurons in vivo produce cycles of high ROS as part of their 
differentiation process and these ROS were confirmed to be developmentally regulated 
(Tsatmali et al., 2006).  Administration of DPI (5 µM) significantly decreased the levels 
of ROS below that observed with NGF addition and halted the maturity of the neurite 
network observed in the previous study.  This is in accordance with an in vivo study 
which demonstrated that administration of antioxidant treatment to cortical progenitor 
cells led to a dramatic increase in the number of poorly differentiated neurons (Tsatmali 
et al., 2006).  Addition of PD123177 eliminated the peak increase produced by 
NGF/AngII treatment and brought ROS levels down to NGF values.  Overall, NADPH 
oxidase appears to be involved in ROS-driven differentiation of PC12 cells and 
angiotensin II seems to induce ROS generation through AT2 receptor activation.  
 
Expression of NADPH oxidase subunits in PC12 cells following short-term NGF 
addition. 
 
                     
 A recently published report demonstrated that Nox1 mRNA was detected in NGF-
stimulated and -unstimulated PC12 cells in accordance with our results, which depicted a 
constant level of expression in naïve PC12 cells and post-NGF addition (Ibi et al., 2006).  
In addition, the same group reported that the peak elevation of Nox1 levels paralleled the 
increase in neurite outgrowth at 72 hours (Ibi et al., 2006).  Although we did not extend 
our examination up to 72 hours, it substantiated our finding that Nox1 protein levels were 
gradually increasing with NGF addition.  Moreover, concomitant NGF and angiotensin II 
addition accelerates PC12 cell differentiation and an earlier Nox1 level increase.  
However, for unknown reasons the Nox transcripts did not always reflect the protein 
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synthesis profile.  However, Nox4 transcript and protein levels remained constant 
following NGF addition. This is in accordance with previous reports stating that Nox4 is 
ubiquitous and produces constitutive levels of ROS, except in certain instances in which 
Nox 4 can be regulated at the transcript level (Lassegue and Clempus, 2003; Lambeth, 
2004).  Interestingly, p47-phox proteins were absent in untreated and NGF-treated cells, 
which paralleled Nox1 protein response.  This is suggestive of a possible collaboration 
between Nox1 and p47-phox for ROS modulation, which was demonstrated in colon 
epithelial and endothelial cells (Banfi et al., 2003; Laufs et al., 2005).  If this holds true, it 
could further the hypothesis that Nox1 requires p47-phox for an optimum activity as was 
reported previously (Banfi et al., 2003; Laufs et al., 2005).  In fact, independent reports 
revealed that Nox1 and p47-phox activation is under the control of Protein Kinase C 
(PKC) (Ago et al., 2003; Geiszt et al., 2003; Wolin, 2004; Sadok et al., 2008).  It is likely 
that PKC produces its effect on both subunits through control of protein translation 
and/or mRNA stability.  Obviously, supplementary analyses are needed to support this 
notion in PC12 cells.  Conversely, p67-phox proteins exist in undifferentiated PC12 cells 
and their levels remain constant after NGF treatment.  This is in accordance with the 
constitutive presence of p67-phox in rabbit aortic adventitia, which was linked to a steady 
generation of ROS (Pagano et al., 1997).   
 
Expression of NADPH oxidase subunits in PC12 cells following short-term 
NGF/AngII addition. 
 
 NGF/AngII addition increased Nox1 and Nox4 at the transcript and protein levels.  
The increase in the catalytic subunits may be linked to higher ROS production. In fact, 
angiotensin II- induced upregulation of NADPH oxidase subunits was linked to increased 
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oxidative stress in tissues such as vascular smooth muscle cell and cardiac cells 
(Lassegue et al., 2001; Chabrashvili et al., 2003; Guzik et al., 2006).  The concurrent 
addition of NGF and angiotensin II increased p47-phox levels as opposed to merely 
absent levels post-NGF administration. Several studies showed that the increase in p47-
phox level was crucial to angiotensin II-induced ROS generation in microvascular 
endothelial, vascular smooth muscle and aortic cells (Murphy et al., 2000; Lavigne et al., 
2001; Li et al., 2002).  These findings suggest that angiotensin II acts as an NADPH 
oxidase activator through gene expression regulation.  On the other hand, the action of 
angiotensin II on NADPH oxidase activity could also stem from a direct involvement in 
upregulation of early-response transcription factors such as c-jun. Indeed, angiotensin II 
increases the expression of seven immediate early gene-encoded transcription factors 
among which is c-jun (Lebrun et al., 1995).  Zohn et al. (1995) showed that angiotensin II 
produced an approximate four-to six-fold increase in JNK (c-Jun N-Terminal kinase) 
activation when compared to growth factors.  In addition, potent activation of JNK was 
detected following addition of ROS to cell culture and use of diphenyleneiodonium (DPI) 
inhibited JNK activity (Lo et al., 1996).   
 
 
Effect of long-term treatment with NGF on NADPH oxidase subunits in PC12 cells 
 
Although long-term addition of NGF did not produce a change at the transcript 
level in nox1 and nox4, their protein levels increased at 8 hours post-NGF treatment. The 
increase in Nox4 levels was detected either concurrent with or following an increase in 
Nox1 levels. Vallet et al. (2005) suggested that Nox4 synthesis is redox-sensitive as 
protein levels increased was ROS-mediated following brain ischemia. In addition, the 
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increase in the protein levels of p47-phox and Nox1 corroborates the fact that Nox1 and 
p47-phox might work in concert (Banfi et al., 2003; Laufs et al., 2005).   
 
Effect of long-term treatment with NGF and angiotensin II (NGF/AngII) on 
NADPH oxidase subunits in PC12 cells. 
 
  
The addition of angiotensin II increased the transcript level of nox1 and nox4 and 
reversed the decrease in p47-phox transcript level detected with NGF addition.  In 
addition, angiotensin II with NGF produced an earlier increase in the protein levels of 
Nox1, Nox4 and p47-phox subunits.  The same experiment was performed using 
angiotensin II alone and neither the RT-PCR nor the western blot analyses showed any 
change at the transcriptional and translational levels of NADPH oxidase (data not 
shown).  This suggests that angiotensin II and NGF act in synergy to upregulate gene 
expression and increase protein levels of the enzyme. Taken all together, the fact that 
angiotensin II and DPI significantly increased and decreased, respectively, ROS 
production and differentiation rate suggests a role for NADPH oxidase in PC12 cells 
differentiation. The increase in protein levels of Nox 1 and p47-phox at 8 hours after 
NGF addition suggests that both subunits are needed to maintain a certain level of ROS 
or possibly produce a second burst. 
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 Chapter III 
NADPH oxidase expression in PC12 cell apoptosis 
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Abstract 
Neurodegeneration could be due to activation of programmed cell death pathways 
targeting specific neurons in the nervous system.  A body of evidence points to oxidative 
stress as a mediating factor in neurodegenerative disease.  In addition, the multi-subunit 
NADPH oxidase is a prominent source of reactive oxygen species (ROS) in different 
tissues including the brain and other cells of the central and peripheral nervous system.  
Preliminary reports from our lab have linked the oxidase to PC12 cell apoptosis; 
however, the subunits involved have not been elucidated. Using NADPH oxidase 
activator (angiotensin II) and inhibitor (diphenylene iodonium, DPI), we demonstrate by 
TUNEL labeling that angiotensin II addition to NGF-deprived PC12 cells accelerates 
apoptosis while DPI significantly reduces cell death.  In addition, angiotensin II causes a 
higher burst of ROS as compared to cells deprived of NGF, while DPI attenuates the 
increase. Withdrawal of NGF produces a significant increase in Nox1, p47-phox, and 
p67-phox protein levels which might indicate their involvement in the machinery of 
PC12 cell apoptotic cascade.  Our results demonstrate that NADPH oxidase may be 
involved in PC12 cell apoptosis and that angiotensin II accelerates this process through 
increasing ROS production. 
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Introduction 
Nerve Growth Factor receptors 
 
NGF acts through two structurally unrelated classes of cell surface receptors, the 
Tyrosine-Receptor Kinase A (TrkA) and p75NGF receptors (Zapf-Colby et al., 1998).  
TrkA is the high-affinity NGF receptor, which is involved in cell survival and 
differentiation (Zapf-Colby et al., 1998).  p75NGF, a transmembrane glycoprotein low-
affinity receptor, exhibits a dual function as a mediator of cell survival and apoptosis 
(Chao and Hempstead, 1995).  In fact, the mode of action of p75NGF is still unclear, 
however it forms a heteromultimeric complex with Trk receptors which increases the 
affinity of TrkA for NGF (Lodish, 2000).  In the absence of TrkA activation, p75 NGF acts 
as a neuronal death factor (Deshmukh and Johnson, 1997; Belliveau et al., 1997).  
Indeed, withdrawal of trophic factor activates p75 NGF and induces sympathetic neuronal 
death (Bamji et al., 1998).  The precise ligand for p75 NGF apoptotic signaling is still 
unclear.  However, stimulation of this receptor results in c-Jun N-terminal Kinase (JNK) 
activation with subsequent stimulation of the caspase cascade (Bakhar et al., 2003). 
Role of Oxidative Stress in neurodegeneration 
Programmed cell death (PCD) is a highly regulated process.  It is under the 
control of intrinsic and extrinsic factors of which oxidative stress has been prominently 
implicated (Putcha et al., 2002; Tsatmali et al., 2005).  Although neurodegenerative 
diseases have different etiologies, at the molecular level they all converge into a 
disadvantageous activation of PCD (reviewed by Kanazawa, 2001).  In fact, reactive 
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oxygen species, nerve growth factor deprivation, and excessive levels of 
neurotransmitters are involved in the pathology of both acute and progressive 
neurodegeneration (Duke and Ojcius, 1996).  Studies done on toxic models revealed that 
cellular disturbances such as oxidative stress trigger neuronal death via activation of PCD 
pathways that lead to apoptosis (reviewed by Halliwell and Whiteman 2004; Halliwell 
and Gutteridge 2006).  In addition, the brain is a susceptible target to oxidative stress as it 
consumes high levels of oxygen and contains high transition metals (Tsay et al., 2000).  
Reduction of these metals by hydrogen peroxide leads to the deleterious hydroxyl free 
radical generation by Fenton-type reactions (Obata, 2003).  Although cells possess an 
intricate network of defense mechanisms to neutralize excess ROS, the brain is much 
more vulnerable to oxidative stress due to restricted antioxidant capacity (Babcock, 
1999).  In addition, the brain has limited access to most antioxidants mainly due to the 
blood-brain barrier. As a consequence, neurons are the first cells to be affected by 
accumulation of ROS (Perry et al., 2004). 
NADPH oxidase contributes to neuronal apoptosis through oxidative stress 
NADPH oxidase has been implicated in apoptosis of sympathetic, cortical and 
hippocampus neurons through production of ROS (Tammariello et al., 2000; Noh and 
Koh, 2000; Tejada-Simon et al., 2005; reviewed by Bedard and Krause, 2007).  Induction 
of neuronal apoptosis linked to NGF withdrawal is mediated by NADPH oxidase. The 
identity of the subunits involved in PC12 cell apoptosis have not been identified 
(Tammariello et al., 2000; Kim et al., 2002).  PC12 cells represent a viable in vitro model 
widely used to study neurodegeneration as these cells become dependent on nerve growth 
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factor (NGF) for survival once they are terminally differentiated (Lambeng et al., 1999).  
This post-mitotic condition mirrors the state of the mature neurons in the brain, which 
makes terminally differentiated PC12 cells a valuable tool to recapitulate neuronal 
apoptosis (Rukenstein et al., 1991).  In fact, upon NGF withdrawal, terminally 
differentiated PC12 cells undergo apoptosis with biochemical and physical characteristics 
similar to neuronal apoptosis (Batistatou and Greene, 1993; reviewed by Valavanis et al., 
2001).  To investigate the putative subunits associated with apoptosis, we analyzed the 
expression and synthesis of NADPH oxidase subunits in terminally differentiated and 
NGF-deprived PC12 cells.  Using a TUNEL assay, we compared cell death following 
treatment with an activator and a pharmacological inhibitor of NADPH oxidase.  We also 
examined ROS production post-treatment with the identical agents. Our results revealed 
that angiotensin II coupled with NGF deprivation produced a higher burst of ROS and 
increased TUNEL-positive cells, which were attenuated by use of DPI and PD123177. In 
addition, NGF withdrawal increased Nox1, p47-phox and p67-phox proteins, which 
suggest a possible role for these subunits in PC12 cell apoptosis. 
Materials and Methods 
 PC12 cell culture 
 
Rat pheochromocytoma (PC12) cells were obtained from the American Type 
Culture Collection (ATCC, Manassas, VA) at an unknown passage.  Cultures were 
maintained at 37°C, 5% CO2 / 95% air in Ham's F-12K growth media supplemented with 
2 mM L-glutamine 15% horse serum; 2.5% fetal bovine serum (Cellgro, Herndon, VA).  
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Cultures were grown in collagen-treated 10-cm culture dishes with media exchange every 
other day (Falcon, San Jose, CA).  For experimental purposes, 6-well, 24-well, or 96-well 
tissue were used (Falcon). For expression studies, the cells were terminally differentiated 
with NGF (50 ng/ml) for ten days. On day 11, NGF deprivation was performed for 2, 4, 
6, 15, 18, 24 and 48 hours.  
 
Cell passage  
 
Cells were analyzed before passaging using a light microscope (Carl Zeiss 
MicroImaging, Inc., Thornwood, New York).  Old media was removed by power suction 
followed by addition of 2 µl of trypsin/EDTA (Sigma). The cells were incubated at 37°C 
for 5 minutes. To stop the proteolytic action of trypsin, 3 ml of culture media were added 
and cells were dispersed by repeated forceful pipetting.  The suspension was transferred 
into a 50-ml BD Falcon Conical tube and the cells were centrifuged at 400 x g for 10 
minutes.  The supernatant was discarded and the cells were resuspended in fresh medium.  
 
TUNEL assay 
 
TUNEL (Terminal Deoxynucleotide Transferase dUTP Nick End Labeling) assay 
is a widely used method to label breaks in the DNA, and is accepted as a hallmark of 
apoptosis.  PC12 cells were terminally differentiated in the presence of NGF for 10 days.  
NGF was removed for 12 and 16 hours and an anti-NGF was added at a concentration of 
1/1000 diluted in F-12K media as described previously.  The different experimental 
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groups included: NGF withdrawal (-NGF), -NGF + angiotensin II (10 µM), -NGF + 
Angiotensin II (10 µM) +PD 123177 (1 µM), and -NGF + Angiotensin II (10 µM) + DPI 
(5 µM). The protocol provided by the manufacturer (APO-BrdU™ TUNEL Assay Kit 
(Invitrogen, Carlsbad, CA) was closely followed.  Briefly, the cells were fixed with 1% 
paraformaldehyde in PBS, subjected to ice-cold 70% (volume/volume) ethanol and stored 
at -20º C for 18 hours.  The fixed cells were resuspended and 1 ml aliquots were added to 
12 x 75 mm flow cytometry tubes.  After centrifugation, the pellet was washed and 
resuspended in 50 µl DNA-labeling solution.  After rinsing, 100 µl of antibody staining 
solution was added per tube. Iodide/RNAse (0.5 ml) staining buffer addition followed.  
The samples were incubated in this solution for 30 minutes in the dark at room 
temperature and analyzed by flow cytometry (Quest Diagnostics, Chantilly, VA). 
Oxidative stress analysis 
 
2’, 7’-dichlorofluorescein diacetate (DCFHDA) assay is a widely used method for 
measuring intracellular reactive oxygen species (ROS).  DCFHDA is converted to DCFH 
by cleavage of its ester bond by means of intracellular esterases.  Non-fluorescent DCFH 
is oxidized to DCF (fluorescent dichlorofluorescein) in the presence of H2O2, which is the 
immediate byproduct of ROS.  Thus, it is a valuable tool to measure intracellular ROS 
generation.  PC12 cells were cultured onto collagen-treated 96-well plates at a 
concentration of 3 x 103 cell/well.  PC12 cells were either maintained in the presence of 
F-12K for ten days (NGF) or deprived of NGF (-NGF) in the presence or absence of  
angiotensin II (10 µM)(-NGF/AngII), angiotensin II + PD123177 (1 µM) (-
NGF/AngII/PD),  DPI (5 µM) (-NGF/DPI), angiotensin II + DPI (5 µM) (-NGF/A/DPI).  
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The experimental time points included 1, 2, 3, 4, 5, 6, 7, 8, 15, 18, 24 and 48 hours post-
NGF withdrawal. NGF-deprivation started 48 hours prior to DCF reading. Cells were 
preloaded with DCFHDA in DMSO (5 µg/ml, Molecular Probes) for 30 minutes at 37 oC.  
All DCFHDA solutions were prepared fresh instantly before the assay.  A multi-channel 
pipette was used to supply 100 µl/well.  The DCF fluorescence was measured using a 
CytoFluor II Fluorescence Plate reader (Applied Biosystems) with an excitation 
wavelength of 485/20 nm and an emission wavelength of 530/35 nm.  
 
RNA isolation procedure 
 
PC12 cells were seeded at a concentration of 0.25 x 106 cells/well onto 24-well 
plates.  Each experimental group comprised four wells.  RNA extraction was carried out 
following the manufacturer's protocol. Briefly, RNA was isolated using 250 µl of Trizol® 
reagent (Gibco Invitrogen, Carlsbad, CA, USA) per well, incubated at room temperature 
for 10 min, and collected in RNAse-free 1.5 ml Eppendorf tubes.  Chloroform (1/5 
volume) was added per 1ml of Trizol®-cell solution. The tubes were manually inverted 
and allowed to incubate for 5 minutes at room temperature.  This was followed by 
centrifugation at 4°C at 7558 x g for 5 min.    The aqueous phase, which contains RNA, 
was transferred into separate 1.5 ml Eppendorf tubes (Westbury, NY). Isopropyl alcohol 
(100%) 1/2 volume was added and the sample was left for 10 minutes at room 
temperature.  Another cold centrifugation at 7558 x g for 15 minutes precipitates the 
RNA pellet, which was washed with 250 µl of 75% ethanol and cold centrifuged at 2516 
x g for 5 minutes.  The ethanol was removed by careful pipetting to avoid disruption of 
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the precipitated RNA, and the pellet was allowed to dry for 10 minutes at room 
temperature and resuspended in RNAse-free DEPC water (0.1%). Quantification of the 
RNA was performed by measuring optical density at 260 nm using a spectrophotometer. 
RNA samples were kept frozen at -80 °C until used. 
 
Reverse Transcription Reaction  
 
Five µg of total RNA was mixed with oligo (dT) primers (50mM) and 10mM 
dNTP in PCR tubes. The combination was heated at 70°C for 5 minutes and immediately 
placed on ice for 2 minutes.  A stock solution of the following was prepared: 6 µl 5 x 
reverse transcription buffer, 1 µl of RNAseOut® (40 U/µl), 1 µl of SuperScript RT III 
(200 U/µl) and 1 µl DTT (0.1M).  Negative controls were prepared with no addition of 
RT to detect any DNA contamination.  Gentle pipetting and a quick spin were performed 
to collect the content.  The stock solution was added to the RNA/oligo (dT) mixture and 
incubated at 50°C for 50 minutes.  The reaction was inactivated at 85°C for 5 minutes.  
To destroy the RNA template, 1 µl of RNAse H (2 units/µl) was added to the mixture and 
followed by incubation at 37°C for 20 minutes.  The cDNA mixture was stored at -20°C 
until use for polymerase chain reaction.  
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Polymerase Chain Reaction (PCR) 
 
Platinum® Taq DNA Polymerase (Sigma, St. Louis, MO) is a recombinant DNA 
polymerase attached to an inhibitory antibody to prevent unnecessary activity at ambient 
temperatures.  Heating the complex to 94°C causes the denaturation of the antibody and 
subsequent activation of the Platinum® Taq DNA Polymerase.  The mixture provides the 
free nucleotides needed for the elongation of the product.  All reagents were mixed and 
centrifuged briefly before addition and were kept on ice.  The reaction mixture was 
prepared in 0.5 ml RNAse-free PCR tubes as follows: 2 unit of Taq Polymerase, 0.6 µl (5 
pmol/µl) of each primer (+/-), and 5 µg of template. The reaction mix was briefly 
centrifuged to ensure homogeneous blending.  All PCR reactions were performed using a  
PCRexpress thermocycler ® (Hybaid Omnigene Thermocycler, UK).  Briefly, the mixture 
was heated to 94°C for 2 minutes to activate Taq polymerase known as the “hot start” 
and denature the DNA.  The first step was followed by an annealing for 30 seconds (the 
temperature used depended on the primer utilized) and an extension step at 72°C for 30 
sec- 1 minute depending on the size of the target product.  The annealing temperatures 
were optimized by doing a temperature gradient PCR starting 5°C below the calculated 
Tm going up to 12°C until the most stringent conditions were found.  Subsequent cycling 
heated the mix at 94°C for only 30 seconds.  The cycle of melting, annealing, and 
extending was repeated between 25-30 times.  Final extension was at 72°C for 10 
minutes. All primers were generated at Integrated DNA Technology (Coralville, IA) and 
are listed in Table 2. 
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Table 2. Primer sequences used in the apoptosis study 
 
Primer Sequence 
nox1 sense 5’-AACCACACGCTGAGACCATTCGA-3’ 
nox1 antisense 5’-TCAGCTAAGGCAGGTTTCCCAGA-3’ 
nox4 sense 5’-AGGTGTCTGCATGGTGGTGGTATT-3 
nox4 antisense 5’-AAAGAGGGCTGTGGCTATCAGCTT-3’ 
p47-phox sense 5’-CAGCCAGCACTATGTGTACAT-3’ 
p47-phox antisense 5’-GAACTCGTAGATATAGGTGAA-3’ 
p67-phox sense 5’-GGGAACCAGCTGATAGACTACAT-3’ 
p67-phox antisense 5’-TCCATTCCTCTTTCTTGGCAATT-3’ 
NSE sense 5’-ACGCTGGACTCGCTGGGCAA-3’ 
NSE antisense 5’-GCGAGCGCGCTGCGCTTGTA-3’ 
 
DNA gel electrophoresis 
 
PCR products were separated on 1-2% agarose gels in 1X TAE (0.04 M Tris-
Acetate, 0.002 M EDTA, pH 8.0).  The electrophoresis apparatus was set at 100 V for 45 
min and 0.5 x SyberGold (Molecular Probes, Eugene, OR) stained the gel for at least 30 
minutes.  The DNA fragments were visualized under ultraviolet light. 
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DNA sequencing 
 
 Identification of PCR products was confirmed by direct DNA sequencing.  cDNA 
sequencing was performed using DYEnamic ET terminator Cycle Sequencing kit® 
 (Amersham Biosciences) according to the manufacturer protocol using ABI Prism® 310 
genetic analyzer (PE Applied Biosystems). 
 
Protein extraction procedure 
 
PC12 cells were seeded at a concentration of 0.25 x 106 cells/well onto 24-well 
plates.  Each experimental group comprised four wells.  Protein extraction was performed 
on ice to prevent further protein modification.  Cells were washed with cold sterile 
phosphate-buffer saline (PBS) (500 µl/well) to remove traces of proteins from the media.  
Cell lysates were collected by scrapping in lysis buffer (1 X 10mM Tris-HCl, 1mM 
EDTA, pH 7.4)   + Protease Inhibitor Cocktail (PIC) (Roche, Mannheim, Germany) + 0.1 
% Triton X+ phosphatase inhibitor).  PIC contains a mixture of proteases that inhibit 
serine, cysteine, and metalloprotease activity.  The composition of the PIC is as follows:  
Chymotrypsin, 1.5 µg/ml, Thermolysin, 0.8 µg/ml, Papain, 1 mg/ml, Pronase, 1.5 µg/ml, 
Pancreatic extract, 1.5 µg/ml, Trypsin, 0.002 µg/ml. Samples were sonicated for cell 
disruption and centrifuged at 4° C 7558 x g for 10 minutes. The supernatant containing 
the protein extract was collected and stored in -80°C until further analysis. 
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Western Blot analysis 
 
Protein concentrations were quantified using serial dilutions of BSA as standards 
for Bradford protein assay (Bio-Rad, Hercules, CA). The BSA solution was added in 
increments of 2µg and assayed in triplicate.   Equal amounts of protein were boiled in 
SDS electrophoresis buffer (containing 2-mercaptoethanol) at 90oC for 10 minutes.  
Protein separation was performed by a 12% SDS-PAGE using Xcell SureLock® 
(Invitrogen).  The proteins were transferred to a polyvinylidene fluoride (PVDF) 
microporous membrane (Millipore Immobion-P #IPVH 000 10, St. Louis, MO) pre-
soaked in 100% methanol and transfer buffer ( 200mM glycine, 25mM Tris, 20% 
methanol) .  Transfer of the blot onto the membrane was performed using Xcell II Blot 
Module® (Invitrogen).  The blot was blocked with 5% non-fat milk in Tris-Buffered 
Saline (27mM Tris, 57 mM NaCl, pH 7.5) for 1 hour at room temperature.  The primary 
antibody was diluted at a concentration of 1:800 in blocking solution and incubated for 
60 minutes at room temperature on a rocker.  The following antibodies were used in this 
study: anti-Nox 1 (cat. 25545, Santa Cruz Biotechnology, Inc., Santa Cruz, CA), anti-
Nox 4 (cat. 5514, Santa Cruz), anti-α-tubulin (cat. 2144, Cell Signaling Technology, Inc., 
Danvers, MA), anti-p47-phox and anti-p67-phox were a generous gift from Dr. Mark 
Quinn (Montana State University). The membrane was washed three times with 1xTBS, 
0.05% Tween 20). A horseradish peroxidase (HRP)-conjugated secondary antibody 
(cat.7074, Cell Signaling Technology, Inc.) diluted in TBS-t (1:1000) was added for 45 
minutes.  Amersham ECL kit (RPN 2106) (GE healthcare, Piscataway, NJ) was prepared 
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following the manufacturer protocol. Band detection was achieved using Kodak X-Ray 
film (Eastman Kodak, Rochester, NY). 
 
Statistics 
 
The results are expressed as the mean + SEM of three or more independent 
experiments.  Significant differences in measured values were evaluated with an analysis 
of a Student’s t-test or ANOVA.  Statistical significance was set at p < 0.05.  Statistical 
analysis and graphing were performed using Microsoft Excel.  
 
Results 
 
Angiotensin II accelerates apoptosis following NGF withdrawal 
 
 
 
A TUNEL assay was performed to examine apoptosis in PC12 cells following 
NGF withdrawal and addition of different pharmacological treatments for 12h and 16h.    
Positive and negative BrdU lymphoma cells (provided by the manufacturer) and NGF-
treated and NGF-deprived PC12 cells were used as controls (Fig.10).  Withdrawal of 
NGF (-NGF) produced a significant increase in TUNEL-positive cells compared to cells 
maintained in NGF (Fig. 11).  Addition of angiotensin II post-NGF withdrawal 
significantly increased the number of TUNEL-positive cells in comparison to NGF-
deprived PC12 cells at 12h while PD123177 significantly reduced the percentage (Table 
3). Furthermore, addition of DPI significantly reduced the percentage of TUNEL positive 
cells in comparison to NGF-deprived PC12 cells at 12h and 16h following NGF removal 
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(Fig. 12).  This suggests that NADPH oxidase may be involved in NGF-deprivation 
induced apoptosis in PC12 cells. 
 
 
 
 
 
Table 3. Average value of TUNEL-positive cells in different treatment groups. The 
numbers represent readings from 3 independent experiments. -NGF: NGF-deprived cells; 
ang II :angiotensin II. * p< 0.05 significant difference from negative control.  ** p<0.05 
significant difference from α-NGF  
 
 
 12h 16h 
Negative Control (+NGF) 4 + 2% 6 + 1% 
-NGF  53   + 6 %* 86  + 7 %* 
-NGF + ang II 85   + 5  %** 92  + 6 % 
-NGF + ang II + PD123177 22   + 2 %** 91  + 4 % 
-NGF + ang II + DPI  27   + 8 %** 32  + 10 %** 
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Figure 10.  TUNEL assay controls.  A) Negative and positive BrdU control lymphoma 
cells were provided by the manufacturer of the APO-BrdU™ TUNEL Assay Kit.  B) 
Negative (+NGF) and positive (-NGF) control PC12 cells as controls for this experiment. 
          Negative Kit Control 
 
          Positive Kit control 
 
              Negative PC12 cells Control 
 
            Positive PC12 cells control 
 
A. 
B.  
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Figure 11.  TUNEL assay following NGF withdrawal and addition of angiotensin II 
in PC12 cells.  Cells were fixed with 1% paraformaldehyde in PBS and incubated in 
DNA-labeling solution.  This was followed by addition of an antibody staining solution 
and iodide/RNAse staining buffer.  The samples were incubated in this solution for 30 
minutes in the dark at room temperature and analyzed by flow cytometry (Quest 
Diagnostics - Chantilly, VA) -NGF: NGF-deprivation. 
         12 hours 
 
         16 hours 
 
-NGF 
 
12 hours 
 
     16 hours 
      -NGF 
  + Angiotensin II 
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Figure 12.  TUNEL assay following NGF withdrawal and co-addition of angiotensin 
II and DPI or PD123177.  Cells were fixed with 1% paraformaldehyde in PBS and 
incubated in DNA-labeling solution.  This was followed by addition of an antibody 
staining solution and iodide/RNAse staining buffer.  The samples were incubated in this 
solution for 30 minutes in the dark at room temperature and analyzed by flow cytometry 
(Quest Diagnostics - Chantilly, VA) -NGF: NGF-deprivation 
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+ Angiotensin II 
+ PD123177 
 
12 hours                          
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 + Angiotensin II 
 + DPI  
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Angiotensin II increases and DPI blocks NGF deprivation induced oxidative stress 
 
 
 
The DCF assay was performed to examine the effect of NGF withdrawal on ROS 
production in the presence or absence of angiotensin II.  NGF deprivation alone and NGF 
deprivation coupled with angiotensin II (-NGF +AngII) produced a peak of ROS at 1 
hour and decreased thereafter (Fig. 13).  However, the angiotensin II group produced 
significantly higher fluorescence (except between 8h and 15h post-treatment). As noticed 
in the DCF study involving differentiation, angiotensin II addition produced an early 
increase in ROS, as the 45-minute values were statistically similar to the 1h values of α-
NGF post-trophic factor withdrawal. These data suggest that the increase in ROS could 
play an important role in accelerating apoptosis of PC12 cells detected in the TUNEL 
experiment.   
The decrease in TUNEL-positive cells following use of PD123177 and DPI 
experiment led us to examine ROS generation following NGF removal and addition of 
those inhibitors. DPI in NGF-deprived PC12 cells resulted in a statistically significant 
decrease in ROS production compared to -NGF cells.  DPI produced a similar effect 
when co-administered with angiotensin II following NGF deprivation. Furthermore, 
concurrent addition of angiotensin II and PD123177 in NGF-deprived PC12 cells led to 
significant lower DCF values when compared to -NGF + AngII values (Fig 13). 
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Figure 13. Angiotensin II increases and DPI attenuates oxidative stress. (A) PC12 
cells were terminally differentiated in NGF for 10 days. Cells were either left in NGF 
(NGF) or NGF-deprived (-NGF) in the presence or absence of angiotensin II (-
NGF/AgII), angiotensin II +PD123177 (-NGF/Ag/PD), DPI, or angiotensin II +DPI (-
NGF/ Ag/DPI).  Treatment started 48h prior to DCF fluorescence reading. Cells were 
pre-loaded with DCFHDA for 30 minutes at 37°C before fluorescence quantification. (B) 
Graphic representation of ROS peak at 1h post-NGF withdrawal (* p < 0.05 significance 
from –NGF). 
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NGF withdrawal produces a parallel increase in Nox1, p47-phox, and p67-phox 
subunits 
 
 
To identify subunits that may be involved in PC12 apoptosis, we examined the 
expression of NADPH oxidase at the transcript and protein levels.  The withdrawal of 
NGF resulted in approximate two-fold increases of p47-phox and p67-phox transcripts 
(Fig. 14A). However, when angiotensin II was administered following NGF withdrawal, 
all subunit transcripts increased significantly suggesting that angiotensin II may have a 
regulatory effect on NADPH oxidase subunit expression (Fig 14B). At the protein level, 
removal of NGF increased Nox1, p47-phox and p67-phox in a similar manner (Fig. 15A). 
Nox4 levels at 4h and 6h post-NGF removal (Fig. 15B). Cells treated with angiotensin II 
concurrent with NGF withdrawal exhibited a similar protein pattern to those cells 
deprived of only NGF, except for Nox 4 which is modestly, but significantly, increased. 
Thus angiotensin II appears to affect the level of transcription, but not translation, in this 
model (Fig. 15B).   
To further examine the long-term effect of NGF withdrawal on the expression and 
synthesis of NADPH oxidase subunits in PC12 cells, we performed RT-PCR and western 
blot analyses on cells 15-48 hours after NGF deprivation.  NGF removal significantly 
increased nox1 and nox4 transcripts, however NGF deprivation resulted in a transient 
downregulation of p47-phox and p67-phox transcripts (Fig. 16A). At the protein level, 
NGF removal significantly increased Nox1, p47-phox and p-67-phox by 15h after NGF 
withdrawal, when compared to the control cells that were maintained in NGF (Fig. 16B) 
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Figure 14.  RT-PCR analysis of NADPH oxidase subunits following NGF removal 
and angiotensin II addition with corresponding densitometry analysis. PC12 cells 
were seeded as described in Materials and Methods. Cells were kept in the presence of 
NGF (Control C) or absence of NGF for 2, 4, and 6 hours (A). Angiotensin II (10 µM) 
was added at same time-points following NGF removal (B). Neuron-specific Enolase is a 
loading control. Minus sign represents withdrawal of NGF. 
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Figure 15.  Western blot analysis of NADPH oxidase subunit expression following 
NGF removal and addition of angiotensin II with corresponding densitometry 
analysis. PC12 cells were seeded as described in Materials and Methods. Cells were kept 
in the presence of NGF (Control C) or absence of NGF for 2, 4, and 6 hours (A). 
Angiotensin II (10 µM) was added at same time-points following NGF removal (B). α-
tubulin is a loading control. Minus sign represents withdrawal of NGF. 
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Figure 16. RT-PCR and western blot analyses of NADPH oxidase subunit following 
long-term NGF deprivation of PC12 cells. Cells were seeded as previously described in 
Materials and Methods. Cells were kept in the presence of NGF (Control C), or in 
absence of NGF for 15, 18, 24 and 48 hours. Loading controls: NSE and α-tubulin are the 
loading controls for the RT-PCR and western blot analyses, respectively. Minus sign 
represents withdrawal of NGF. 
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Discussion 
 
 
Angiotensin II accelerates apoptosis while DPI and PD123177 slow down the rate of 
PC12 cell death 
 
 
NGF withdrawal produced about a 50% increase in TUNEL positive staining 
when compared to the negative control at 12h post-NGF removal.  This is in agreement 
with Vaghefi et al. (2004) who reported that half of the terminally differentiated PC12 
cells were no longer viable at 12h following NGF-deprivation.  Furthermore, cells treated 
with  angiotensin II coincident with NGF withdrawal exhibited a significantly higher 
percentage of TUNEL positive cells 12h after NGF withdrawal.  This substantiates 
previous data from our laboratory, which showed that angiotensin II produced an 
accelerated apoptosis in NGF-deprived sympathetic neurons (Hilburger, 2004).  The AT2 
antagonist, PD123177, counteracted the angiotensin II effect for up to 12 hours, which 
substantiates other reports that angiotensin II exerts its apoptotic action mainly through 
AT2 receptor stimulation (Yamada et al., 1996; Dimmeler et al., 1997; Wang et al., 
1999).  However, the percentage of TUNEL positive PD123177-treated cells was 
statistically similar to -NGF values by 16h post-NGF withdrawal. This suggests that an 
increase in AT2 receptor synthesis may have occurred and/or receptor activation took 
place between 12 and 16 hours. When DPI was co-administered with angiotensin II to 
NGF-deprived cells, the percentage of TUNEL positive cells dropped significantly at 
both times substantiating previous reports from our laboratory that DPI decreased 
apoptosis in NGF-deprived sympathetic neurons, even when treated with angiotensin II 
(Hilburger, 2004). 
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Angiotensin II produces a higher burst of oxidative stress following NGF 
withdrawal from PC12 cells 
 
 
Angiotensin II-induced cellular apoptosis has been established in epithelial and 
endothelial cells (Dimmeler et al., 1997; Wanget al., 1999).  The results from the TUNEL 
study point toward a comparable involvement in PC12 cells.  In fact, most of the 
documented angiotensin II–mediated cellular action including apoptosis was linked to 
oxidative stress (Griendling et al., 1994; Imanishi et al., 2005; Mehta and Griendling, 
2007).  DCF analysis of –NGF/AngII-treated cells revealed that apoptosis was preceded 
by a significant elevation in ROS when compared to the burst observed in PC12 cells 
deprived of NGF alone. In fact, the -NGF and - NGF/AngII groups produced a ROS peak 
at 1h post-NGF withdrawal.  However, - NGF/AngII values were significantly higher at  
all times except for 8h-15h time-points. - NGF/AngII addition generated an earlier 
increase in ROS as the 45- minute values were statistically similar to the 1h values of the 
–NGF cells .  Our laboratory has detected a similar result in sympathetic neurons 
(Hilburger, 2004).  The early increase in angiotensin II-mediated ROS could be due in 
part to enhanced expression of NADPH oxidase subunits or enzyme activation.  
Interestingly, a second moderate increase in ROS was depicted at 18h, which could be 
NADPH oxidase related and/or mitochondrial-mediated. Lee et al (2006) proposed that 
Nox1 and mitochondria work jointly to extend the production of ROS as the 
mitochondrial reactive oxygen species are not enough to promote cell death, which is a 
process that requires a sustained production of ROS.  However, since higher values were 
produced with angiotensin II this might further indicate that a higher number of AT2 
receptors are synthesized and /or activated as apoptosis progresses.   
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NADPH oxidase and AT2 inhibitors decrease ROS production in NGF-deprived 
PC12 cells 
 
DPI treatment produced a significant decrease in DCF values as compared to -
NGF which suggests that NADPH oxidase may be a source of ROS in PC12 cells as 
reported by others (Tammariello et al., 2000; Beddard et al., 2007).  Interestingly, co-
administration of PD123177 with angiotensin II in NGF deprived cells completely 
abolished the angiotensin II-induced ROS production and resulted in DCF values 
significantly lower from the values observed in NGF deprived cells. This proposes a 
possible role for the AT2 receptor in PC12 cell apoptosis as suggested by other 
investigators (Yamada et al., 1996; Horiuchi et al., 1997).  AT2 receptor involvement in 
PC12 cell apoptosis may be crucial as these receptors were reported to have a ligand-
independent constitutive apoptotic function (Miura and Karmic, 2000).   
 
Nox1, p47-phox, and p67-phox proteins increase following withdrawal of NGF  
 
NGF-withdrawal resulted in differential expression of p47-phox and p67-phox 
transcripts with no effect on nox1 and nox4 mRNAs following short-term NGF 
withdrawal. Nox1, p47-phox and p67-phox also increased significantly at the protein 
level post-NGF removal.  Previous reports indicate that p47-phox and p67-phox are 
crucial for optimal Nox 1 activity and are required to sustain certain level of ROS 
production (Geiszt et al., 2003; Bedard and Heinz-Krause, 2007). When the same 
experiment was repeated with the addition of angiotensin II, nox1 and nox4 transcripts 
were upregulated. No increase however was detected for p47-phox and p67-phox.  We 
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observed a similar pattern of increase for Nox1, p47-phox and p67-phox at the level of 
translation. The addition of angiotensin II had no significant effect at the protein level. 
Following long-term NGF withdrawal, nox1 and nox4 transcripts were upregulated.  p47-
phox and p67-phox transcripts, however exhibited a transient downregulation. This is 
suggestive that the regulation of these two transcripts could be linked to the overall 
activity of the enzyme.  This proposition is supported by a body of evidence pointing 
toward the existence of regulatory factors unique to oxidase genes in phagocytic NADPH 
oxidase (Li et al., 2001).  In fact, Skalnik et al. (1991) demonstrated that there are 
repressor proteins that bind the positive promoters of NADPH oxidase genes to repress 
transcription when needed.  Although, this report showed that the repressor protein was 
tissue-specific, similar regulatory factors could exist in PC12 cells.  Taken together, 
NADPH oxidase may play a role in PC12 cell apoptosis as suggested by the increase in 
the rate of TUNEL positive cells following enzyme activator addition, angiotensin II. 
Similarly, the decrease in the TUNEL positive cell number following DPI addition, the 
enzyme inhibitor furthers this proposition. Nox1, p47-phox and p-67-phox may play a 
role in the apoptotic process as their protein levels were elevated following NGF 
withdrawal. 
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c-Jun and AT2 receptors  
expression and synthesis in PC12 cells  
differentiation and apoptosis 
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Abstract 
PC12 cell differentiation and apoptosis are processes that require the activation of 
c-Jun by the c-Jun N-terminal kinase (JNK).  Similarly, angiotensin II-type 2 (AT2) 
receptors are involved in cellular differentiation and apoptosis of PC12 cells.  In addition, 
c-Jun and AT2 receptors independently were shown to induce neuronal regeneration. We 
investigated the effect of angiotensin II on c-jun expression, synthesis, and 
phosphorylation as possible mediators of cellular apoptosis and differentiation.  A 
parallel study examined the expression of AT2 receptors, which are necessary for 
angiotensin II-induced cellular differentiation and apoptosis.  Here we report that NGF 
treatment of PC12 cells upregulates c-jun expression and increases protein levels and 
phosphorylation of c-Jun proteins.  Concurrent addition of angiotensin II with NGF 
induces higher levels of total and phosphorylated c-Jun leading to enhanced 
transcriptional activation of c-jun.  Further, NGF treatment increases AT2 receptors at the 
transcriptional and translational levels. However, NGF co-administered with angiotensin 
II leads to an earlier expression of AT2 receptor transcript and protein synthesis that are 
abolished by use of DPI and PD123177.  c-jun expression and phosphorylation decrease 
following NGF withdrawal from terminally differentiated PC12 cells.  This suggests that 
signaling pathways may be switching from survival/ differentiation to death signaling.  
Furthermore, AT2 receptors exhibit an angiotensin II-independent upregulation following 
NGF deprivation. Overall, these results indicate that angiotensin II plays a critical role in 
c-Jun regulation in differentiation and apoptosis of PC12 cells. In addition, AT2 receptors 
are involved in these two processes; however their implication in apoptosis is angiotensin 
II-independent as well. 
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Introduction 
 
The c-Jun transcription factor is upregulated during PC12 cell differentiation 
 
NGF-induced Trk phosphorylation stimulates Ras through recruitment of adaptor 
proteins such as Grb-2 and SOS-1 (Obermeier et al., 1993; 1994).  The MAP kinase 
cascade, downstream of Ras, results in the activation of c-Fos and c-Jun transcription 
factors which have been linked to neurite outgrowth and axonal regeneration (Smeal et 
al., 1991; Pulverer et al., 1991; Dragunow et al., 1993).  c-Jun is an inducible 
transcription factor capable of gearing PC12 cell gene expression toward cellular 
differentiation and apoptosis depending on the extracellular stimuli and subsequent 
signaling pathway activation (Angel and Karin, 1991).  In addition, c-Jun activity is 
controlled largely at the protein level. Regulatory phosphorylations take place on four N-
terminal sites which are Ser63, Ser73, and Thr91 and /or and Thr93 residues (Pulverer et 
al., 1991).  The posttranslational modifications confer stabilization and enhanced c-Jun/ 
DNA binding interaction (Papavassiliou et al., 1995). These regulatory phosphorylations 
are linked to MAP kinases, ERK1 and ERK2, which receive their signals from activated 
Ras subsequent to Trk receptor stimulation (Smeal et al., 1991; Pulverer et al., 1991).  In 
addition, in vitro and in vivo studies suggest that c-jun expression in neurons might be 
involved in axonal regeneration after axotomy (Jenkins and Hunt, 1991; Dragunow et al., 
1993).  In fact, damage to peripheral axons in rat produced a long-term c-jun expression 
in neuronal cell bodies and all c-Jun-positive peripheral neurons were able to project into 
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the spinal cord. However, c-jun expression returned to basal levels after full axonal 
recovery (Jenkins et al., 1993). 
 
NGF removal activates the N-terminal Jun Kinase (JNK) pathway  
 
JNK is a member of the mitogen-activated protein kinase superfamily.  It is 
activated by a variety of extracellular stimuli such as some growth factors, G protein-
coupled receptors and ultraviolet light (Kyriakis et al., 1994; Derijard et al., 1994).  JNK 
phosphorylates the N-terminal of c-Jun transcription factor that has been correlated with 
cellular stress and neuronal death.  Phosphorylated c-Jun homodimerizes or forms 
heterodimers with members of the c-Fos superfamily, and acquires an activator protein-1 
(AP-1) property that controls the expression of many different genes including c-jun itself 
(Angel and Karin, 1991).  Studies have reported c-Jun kinase to be an obligate 
component of the cell death pathway in neuronal and PC12 cells (Xia et al., 1995; Park et 
al., 1996).  Inhibition of JNK activity prevented death of motor, sympathetic neurons and 
PC12 cells (Maroney et al., 1997). Furthermore, N-terminal phosphorylation of c-Jun has 
been found to be involved in programmed cell death in the adult brain.  After ischemia-
reperfusion, c-Jun expression is bilaterally induced in the cortical hemispheres. N-
terminal phosphorylation, however was only detectable in neurons of infarcted areas 
(Herdegen et al., 1998).  JNK activation occurs by a post-translational mechanism.  In 
fact, addition of a transcriptional terminator (actinomycin D) concomitant with trophic 
factor deprivation led to an increase in JNK stimulation (Ham et al., 2000).  This implies 
that JNK activation is independent of gene upregulation in response to trophic factor 
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withdrawal. In addition, Bcl-2 the anti-apoptotic protein appears to block death of NGF-
deprived PC12 cells by acting upstream of JNK stimulation (Park et al., 1996).  JNK 
signaling is particularly implicated in ischemic stroke and Parkinson's disease, which 
makes it an attractive target for therapeutic intervention (Kuan and Burke, 2005). There 
are three known isoforms of JNK: JNK1, 2 and 3 which are all encoded by 3 independent 
genes. JNK1 and JNK2 have a less specific expression profile, whereas JNK3 expression 
is believed to be restricted to the central nervous system.  JNK3 deficiency proved 
neuroprotective in NGF-deprived sympathetic neurons and gene JNK3- knockout 
prevented excitotoxic cell death of hippocampal neurons suggesting that JNK3 mediates 
neuronal apoptosis (Yang et al., 1997; Bruckner et al., 2001).  However, JNK3 does not 
contribute to oxidative stress following NGF withdrawal, which implies that it is not 
involved in NADPH oxidase activation (Bruckner et al., 2001).   
 
AT2 receptors are important in cellular differentiation 
 
The high expression of AT2 receptor during fetal and neonatal development has 
suggested that this receptor may be involved in tissue growth and/or differentiation 
(Nakajima et al., 1995). In healthy adult, the AT2 receptor is only expressed in restricted 
tissues such as parts of the brain, vascular endothelial cells, the adrenal and cardiac 
structures, myometrium and ovaries (de Gasparo et al., 2000). However, the AT2 
receptor is upregulated in response to certain pathophysiological conditions in adults 
(Gallinat et al., 1998; Nio et al, 1995). In addition, AT2 receptor activation induces 
neuronal regeneration. Axotomy of both dorsal root ganglia, sciatic and optic nerves 
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significantly upregulated AT2 expression (Lucius et al., 1998; Gallinat et al., 1998).  The 
specific mechanism(s) of the AT2-induced effects are still unknown. It is believed, 
however to ensue through the same signaling that leads to the cytoskeleton rearrangement 
during neuronal differentiation (Gendron et al., 2003). One of the prominent roles 
attributed to the AT2 receptor is induction of neurite outgrowth and elongation by 
increasing the polymerization of microtubules (Meffert et al., 1996; Stroth et al., 1998).   
Data on the effect of trophic factors on AT2 expression are limited. Shanmugam 
and colleagues (1995) showed that AT2 mRNA was elevated during development of rat 
kidney as long as the trophic factor was in good supply during embryogenesis. A 
subsequent decrease in AT2 expression was concomitant with the completion of 
nephrogenesis (Shanmugam et al., 1995). 
 
AT2 receptors induce apoptosis in terminally differentiated PC12cells 
 
The AT2 receptor is also known to play an important role in cellular apoptosis 
(Yamada et al., 1996; Horiuchi et al., 1997).  Serum starvation-induced apoptosis can be 
salvaged by the addition of trophic agents such as nerve growth factor (Pittman et al., 
1993).  However, concurrent angiotensin II administration with trophic factor nullified 
the protective effect of NGF and induced apoptosis by potential upregulation of AT2 
expression (Yamada et al., 1996).  In addition, angiotensin II increased AT2 receptor 
mRNA level in rat cortical cells in a dose-dependent manner, which led eventually to 
apoptosis (Shibata et al., 1997; Makino et al., 1998).   
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The dual effect of AT2 receptor on cellular differentiation and apoptosis provides 
evidence that the cellular response of this receptor is dictated by the presence or absence 
of serum and trophic growth factors such as NGF (Gendron et al., 2003).  During cellular 
proliferation or differentiation, the AT2 receptor is hypothesized to cross-talk with 
signaling proteins that gear its effect toward these two processes (Gendron et al., 2003).  
In the absence of serum or NGF, thus of those signaling proteins, the activation of AT2 
receptor induces apoptosis.  In fact, Miura and Karnik (2000) proposed that the induction 
of apoptosis is a constitutive function of the AT2 receptor. The latter produces low 
angiotensin II-independent apoptosis signals that activate p38 MAPK and caspase-3.  In 
addition, the same group demonstrated that a specific conformation of the AT2 receptor 
is required for those low signals to be produced (Miura et al., 2000). Moreover, mutations 
in the AT2 receptor or use of pharmacological agents that interrupt apoptotic signals have 
abolished AT2-mediated cell death of R3T3 cells and vascular smooth muscle cells 
(Miura et al., 2000).  
There is a possible cross-talk between serum-deprivation induced AT2 receptor 
activation and JNK signaling in PC12 cell apoptosis (Xia et al., 1995).  Activation of the 
p38 MAPK was reported independently to induce apoptosis via JNK and AT2 receptor 
stimulation (Xia et al., 1995; Yamada et al., 1996). In addition, activation of AT2 
receptor increases the expression of MAPK phosphatase-1 (MKP-1), which 
dephosphorylates ERK1/2 and Bcl-2 leading to cell death (Yamada et al., 1996; Horiuchi 
et al., 1997).  
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AT2 signaling in cellular differentiation and apoptosis 
 
Although this receptor belongs to the seven-transmembrane domain receptor 
family, it does not exhibit G protein-coupled receptor characteristics regarding agonist 
affinity and ability to activate second-messengers (Kambayashi et al., 1993).  In fact, its 
mode of action is believed to be independent of adenylyl cyclase and PKA, the classical 
pathways for the family of G protein-linked membrane receptors (Bottari et al., 1993). 
However, a growing body of evidence points to its involvement with Gαi and subsequent 
activation of cGMP in neurons (Sumners et al., 1991).  Signal transduction cascades 
following AT2 receptor activation appear to involve protein phosphatases acting either on 
tyrosine or serine/threonine residues (Tsuzuki et al., 1996; Yamada et al., 1996).  
Angiotensin II-induced cellular differentiation in the presence of trophic factors has been 
linked to ERK1/2 activity.  As mentioned above, serum-deprivation induced apoptosis 
has been associated with p38 MAPK pathway activation (Wang et al., 1998; Gendron et 
al., 1999).   
Angiotensin II has shown to accelerate the rate of PC12 cell differentiation and 
apoptosis.  We wished to examine the effect of angiotensin II on c-Jun expression, 
synthesis, and phosphorylation during these two cellular events.  In addition, AT2 
receptors proved to play a crucial role in both PC12 cell differentiation and apoptosis.  
Use of PD123177 during ROS production differentiation and cell death consistently 
antagonized the effect of angiotensin II.  The PD123177 response was as effective as the 
cellular effect of DPI. Therefore, a parallel examination of AT2 receptor expression and 
synthesis was performed during PC12 cell differentiation and apoptosis.  We report that 
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angiotensin II addition concurrent with NGF addition significantly increases total and 
phosphorylated c-JUN and AT2 expression and protein levels as compared to NGF 
addition alone. Withdrawal of NGF from terminally differentiated PC12 cells transiently 
downregulates c-Jun expression and phosphorylated proteins and increases transcript and 
protein levels of AT2 receptors. Taken together, c-Jun and AT2 receptors may play a role 
in PC12 cell differentiation and apoptosis and that the combined effect of NGF and 
angiotensin II addition to PC12 cells may be to enhance transcription and synthesis of 
these two molecules. 
 
Materials and Methods 
 
PC12 cell culture 
 
Rat pheochromocytoma (PC12) cells were obtained from the American Type 
Culture Collection (ATCC, Manassas, VA) at an unknown passage.  Cultures were 
maintained at 37°C, 5% CO2 / 95% air in Ham's F-12K growth media supplemented with 
2 mM L-glutamine 15% horse serum; 2.5% fetal bovine serum (Cellgro, Herndon, VA).  
Cultures were grown in collagen-treated 10-cm culture dishes with media exchange every 
other day (Falcon, San Jose, CA).  For experimental purposes, 6-well, 24-well, or 96-well 
tissue were used (Falcon). For c-jun and AT2 expression analyses following NGF 
addition, the cells were treated with NGF (50 ng/ml) or NGF (50 ng/ml) + angiotensin II 
(10 µM) (NGF/AngII) for different experimental time points (2, 4, 6, 8, 18, 24 and 48h). 
To study the effect of DPI and PD123177, PC12 cells with were either treated with NGF 
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(50 ng/ml) + angiotensin II (10 µM) + DPI (5 µM ) or with NGF(50 ng/ml) + angiotensin 
II (10 µM) + PD123177 (1 µM). Terminally differentiated PC12 cells were in the 
presence of NGF for 10 days. NGF withdrawal was performed at 2, 4, 6 15, 18 24 and 48 
hours prior to RNA and protein collection. All controls were cells left in F12-K media. 
 
Cell passage  
 
Cells were analyzed before passaging using a light microscope (Carl Zeiss 
MicroImaging, Inc., Thornwood, New York).  Old media was removed by power suction 
followed by addition of 2 ul of trypsin/EDTA (Sigma). The cells were incubated at 37°C 
for 5 minutes. To stop the proteolytic action of trypsin, 3 ml of culture media was added 
and cells were dispersed by repeated forceful pipetting.  The suspension was transferred 
into a 50-ml BD Falcon Conical tube and the cells were centrifuged at 400 x g for 10 
minutes.  The supernatant was discarded and the cells were resuspended in fresh medium.  
 
RNA isolation procedure 
 
PC12 cells were seeded at a concentration of 0.25 x 106 cells/well onto 24-well 
plates.  Each experimental group comprised four wells.  RNA extraction was carried out 
following the manufacturer's protocol. Briefly, RNA was isolated using 250 µl of Trizol® 
reagent (Gibco Invitrogen, Carlsbad, CA, USA) per well, incubated at room temperature 
for 10 min, and collected in RNAse-free 1.5 ml Eppendorf tubes.  Chloroform (1/5 
volume) was added per 1ml of Trizol®-cell solution. The tubes were manually inverted 
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and allowed to incubate for 5 minutes at room temperature.  This was followed by 
centrifugation at 4°C at 7558 x g for 5 min. The aqueous phase, which contains RNA, 
was transferred into separate 1.5 ml Eppendorf tubes (Westbury, NY). Isopropyl alcohol 
(100%) 1/2 volume was added and the sample was left for 10 minutes at room 
temperature.  Another cold centrifugation at 7558 x g for 15 minutes forms the RNA 
pellet, which was washed with 250 µl of 75% ethanol and cold centrifuged at 2516 x g 
for 5 minutes.  The ethanol was removed by careful pipetting to avoid disruption of the 
precipitated RNA, and the pellet was allowed to dry for 10 min at room temperature and 
resuspended in RNAse-free DEPC water (0.1%). Quantification of the RNA was 
performed by measuring optical density at 260 nm using a spectrophotometer. RNA 
samples were kept frozen at -80 °C until used. 
 
Reverse Transcription Reaction  
 
Five µg of total RNA was mixed with oligo (dT) primers (50mM) and 10mM 
dNTP in PCR tubes.  The combination was heated at 70°C for 5 minutes and immediately 
placed on ice for 2 minutes.  A stock solution of the following was prepared: 6 µl 5 x 
reverse transcription buffer, 1 µl of RNAseOut® (40 U/µl), 1 µl of SuperScript RT III 
(200 U/µl) and 1 µl DTT (0.1M).  Negative controls were prepared with no addition of 
RT to detect any DNA contamination.  Gentle pipetting and a quick spin were performed 
to collect the content.  The stock solution was added to the RNA/oligo (dT) mixture and 
incubated at 50°C for 50 minutes.  The reaction was inactivated at 85°C for 5 minutes.  
To destroy the RNA template, 1 µl of RNAse H (2 units/µl) was added to the mixture and 
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followed by incubation at 37°C for 20 minutes.  The cDNA mixture was stored at -20°C 
until use for polymerase chain reaction.  
 
Polymerase Chain Reaction (PCR) 
 
Platinum® Taq DNA Polymerase (Sigma, St. Louis, MO) is a recombinant DNA 
polymerase attached to an inhibitory antibody to prevent unnecessary activity at ambient 
temperatures.  Heating the complex to 94°C causes the denaturation of the antibody and 
subsequent activation of the Platinum® Taq DNA Polymerase.  The mixture provides the 
free nucleotides needed for the elongation of the product.  All reagents were mixed and 
centrifuged briefly before addition and were kept on ice.  The reaction mixture was 
prepared in 0.5 ml RNAse-free PCR tubes as follows: 2.0 unit of Taq Polymerase, 0.6 µl  
(5pmole) of each primer (+/-), and 5 µg of template in 15 µl reaction . The reaction mix 
was briefly centrifuged to ensure homogeneous blending.  All PCR reactions were 
performed using a PCRexpress thermocycler ® (Hybaid Omnigene Thermocycler, UK).  
Briefly, the mixture was heated to 94°C for 2 minutes to activate Taq polymerase known 
as the “hot start” and denature the DNA.  The first step was followed by an annealing for 
30 seconds (the temperature used depended on the primer utilized) and an extension step 
at 72°C for 30 sec- 1 minute depending on the size of the target product.  The annealing 
temperatures were optimized by doing a temperature gradient PCR starting 5°C below 
the calculated Tm going up to 12°C until the most stringent conditions were found.  
Subsequent cycling heated the mix at 94°C for only 30 seconds.  The cycle of melting, 
annealing, and extending was repeated between 25-30 times.  Final extension was at 
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72°C for 10 minutes. All primers were generated at Integrated DNA Technology 
(Coralville, IA) and are listed in Table 4. 
 
Table 4. Primer sequences used in this study 
 
Primer Sequence 
NSE sense 5’-ACGCTGGACTCGCTGGGCAA-3’ 
NSE antisense 5’-GCGAGCGCGCTGCGCTTGTA-3’ 
c-jun sense 5’-CTGAAGCAGAGCATGACCTTGAAC-3’ 
c-jun anti-sense 5’-TTCTGGCTAAGTTCAGCTAGG-3’ 
AT2 sense 5’-TTGCTGCCACCAGCAGAAACT-3’ 
AT2 anti-sense 5’-GTGTGGGCCTCCAAACCATTGCTA-3’ 
 
DNA gel electrophoresis 
 
PCR products were separated on 1-2% agarose gels in 1X TAE (0.04 M Tris-
Acetate, 0.002 M EDTA, pH 8.0).  The electrophoresis apparatus was set at 100 V for 45 
min and 0.5 x SyberGold (Molecular Probes, Eugene, OR) stained the gel for at least 30 
minutes.  The DNA fragments were visualized under ultraviolet light. 
DNA sequencing 
 
 Identification of PCR products was confirmed by direct DNA sequencing.  cDNA 
sequencing was performed using DYEnamic ET terminator Cycle Sequencing kit® 
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 (GE Healthcare, formerly Amersham Bioscience, Piscataway, NJ) according to the 
manufacturer protocol using ABI Prism® 310 genetic analyzer (PE Applied Biosystems, 
PE Applied Biosystems, Foster City,. CA). 
 
Protein extraction procedure 
 
In order to obtain samples for western blot analysis, PC12 cells were seeded at a 
concentration of 0.25 x 106 cells/well onto 24-well plates.  Each experimental group 
comprised four wells.  Protein extraction was carried on ice to prevent further protein 
modification.  Cells were washed with cold sterile phosphate-buffer saline (PBS) (500 
µl/well) to remove traces of proteins from the media.  Cell lysates were collected by 
scrapping in lysis buffer (1 X 10mM Tris-HCl, 1mM EDTA, pH 7.4) + Protease Inhibitor 
Cocktail (PIC) (Roche, Mannheim, Germany) + 0.1 % Triton X+ phosphatase inhibitor).  
PIC contains a mixture of proteases that inhibit serine, cysteine, and metalloprotease 
activity.  The composition of the PIC is as follows:  Chymotrypsin, 1.5 µg/ml, 
Thermolysin, 0.8 µg/ml, Papain, 1 mg/ml, Pronase, 1.5 µg/ml, Pancreatic extract, 1.5 
µg/ml, Trypsin, 0.002 µg/ml.  Samples were sonicated for cell disruption and centrifuged 
at 4° C 7558 x g for 10 minutes. The supernatant containing the protein extract was 
collected and stored in -80°C until further analysis 
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Western Blot analysis 
 
Protein concentrations were quantified using serial dilutions of BSA as standards 
for Bradford protein assay (Bio-Rad, Hercules, CA).  The BSA solution was added in 
increments of 2µg and assayed in triplicate. Equal amounts of protein were boiled in SDS 
electrophoresis buffer (containing 2-mercaptoethanol) at 90oC for 10 minutes.  Protein 
separation was performed by a 12% SDS-PAGE using Xcell SureLock® (Invitrogen).  
The proteins were transferred to a polyvinylidene fluoride (PVDF) microporous 
membrane (Millipore Immobion-P #IPVH 000 10, St. Louis, MO) pre-soaked in 100% 
methanol and transfer buffer ( 200mM glycine, 25mM Tris, 20% methanol) .  Transfer of 
the blot onto the membrane was performed using Xcell II Blot Module® (Invitrogen).  
The blot was blocked with 5% non-fat milk in Tris-Buffered Saline (27mM Tris, 57 mM 
NaCl, pH 7.5) for 1 hour at room temperature.  The primary antibody was diluted at a 
concentration of 1:800 in blocking solution and incubated for 60 minutes at room 
temperature on a rocker.  The following antibodies were used in this study: anti-c-Jun 
(cat. 9165, Cell Signaling Technology, Inc., Danvers, MA), anti-Ser63-c-Jun (cat. 9261, 
Cell Signaling Technology, Inc.), anti-AT2 (cat. 9040, Santa Cruz Biotechnology, Inc., 
Santa Cruz, CA) and anti-α-tubulin (cat. 2144, Cell Signaling Technology, Inc., Danvers, 
MA). The membrane was washed three times with 1xTBS, 0.05% Tween 20).  A 
horseradish peroxidase (HRP)-conjugated secondary antibody (cat.7074, Cell Signaling 
Technology, Inc.) diluted in TBS-t (1:1000) was added for 45 minutes.   
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Amersham ECL kit (RPN 2106) (GE healthcare, Piscataway, NJ) was prepared following 
the manufacturer protocol. Band detection was achieved using Kodak X-Ray film 
(Eastman Kodak, Rochester, NY) 
 
Statistics 
 
 
The results are expressed as the mean + SEM of three or more independent 
experiments.  Significant differences in measured values were evaluated with an analysis 
of a Student’s t-test or ANOVA.  Statistical significance was set at p < 0.05.  Statistical 
analysis and graphing were performed using Microsoft Excel.  
 
 
Results 
 
Angiotensin II increases c-jun expression and phosphorylation in NGF-treated PC12 
cells 
 c-jun expression was examined at the mRNA level by RT-PCR analysis.  
Exposure to NGF substantially increased the mRNA level at 2h with a slight reduction 
observed by 4h after NGF addition (Fig. 17A). On the other hand, angiotensin II co-
incubation with NGF (NGF/AngII) produced a gradual increase in c-jun transcript at 2h 
and 4h and produced approximately a 1.5 fold increase in c-jun transcript levels. In 
addition, angiotensin II not only prevented the decrease of c-jun at 4h detected with NGF 
addition but also maintained a progressive elevation in c-jun expression (Fig. 17B).  
Western blot analysis revealed that the addition of NGF to undifferentiated PC12 cells 
increased total and phosphorylated c-Jun protein (the activated form) paralleling the 
transcript elevation (Fig. 18A). Moreover, NGF/AngII produced a gradual increase in 
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total and Ser63-phospho c-Jun (Fig. 18B). The increase in c-Jun expression and 
phosphorylation following NGF/AngII addition might in part explain the increased level 
of PC12 cell differentiation depicted previously with addition of NGF/Ang II. 
c-Jun expression and phosphorylation at Ser63, but not total c-Jun, produce a 
parallel response following NGF withdrawal 
 
c-jun expression following NGF withdrawal from differentiated PC12 cells was 
examined by RT-PCR.  c-jun transcript levels significantly decreased (by approximately 
two-fold) at 4h and reappeared at 6h (Fig. 19A).  This finding was enigmatic since it was 
anticipated that c-jun transcript levels increase and remain high during the early stages of 
apoptosis.  When long-term time points were examined, c-jun expression was high and 
constitutive during the later stage of apoptosis (Fig. 19B). Western blot analysis revealed 
a gradual decrease in total c-Jun levels during the first 6 hours of NGF deprivation. 
Surprisingly, Ser63-phospho-c-Jun exhibited a decrease that paralleled the transcript 
levels. The phosphorylated c-Jun levels were up at 2h, completely down by 4h and re-
appeared at 6h after NGF withdrawal (Fig. 20A). This led us to examine the 
phosphorylation state of c-Jun at Ser63 more closely by performing a western blot 
analysis including earlier time points. The immunoblotting depicted a robust Ser63 
phosphorylation at 30 and 60 minutes. By 2h, the levels started to subside with complete 
disappearance at 3h and 4h and reappearance at 5h (data not shown). It is unclear what 
caused the transient elimination of phosphorylated c-Jun.  However, protein levels of 
total c-Jun and phospho-c-Jun show similar increasing patterns following long-term NGF 
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withdrawal (Fig. 20B).   This data shows that the phosphorylation status of c-Jun mimics 
the pattern of transcription of the c-jun gene after short-term NGF withdrawal.  
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Figure 17.  RT-PCR analysis of c-Jun expression in the presence of NGF or NGF 
and angiotensin II with corresponding densitometry.  PC12 cells were cultured as 
described in Materials and Methods.  Twenty-four hours after seeding, cells were kept in 
regular F-12 K media (C, control) or treated with either NGF-supplemented F-12K (50 
ng/ml) (A) or NGF (50 ng/ml) and angiotensin II (10 uM) (NGF/AngII) (B)  for 2 and 4 
hours (+2h, +4h, respectively).  Densitometry values are means of three independent 
experiments and represent values corrected for loading control (* p < 0.05).  Equal 
loading control is Neuron Specific Enolase (NSE). 
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Figure 18. Western blot analysis with corresponding densitometry quantification of 
total and phosphor-c-Jun following NGF and NGF/Ang II addition with 
corresponding densitometry quantification.  PC12 cells were cultured as described in 
Materials and Methods.  Twenty-four hours after seeding, cells were kept in regular F-12 
K media (C, control) or treated with either NGF-supplemented F-12K (50 ng/ml) (A) or 
NGF (50 ng/ml) and angiotensin II (10 uM) (NGF/AngII) (B)  for 2 and 4 hours (+2h, 
+4h, respectively).  Densitometry values are means of three independent experiments.  
Asterisk denotes statistical difference from the control.  a-b: Values with different letters 
are significantly different.  (p < 0.05).  α-tubulin is a loading control.  
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Figure 19.  RT-PCR analysis of c-jun expression following NGF withdrawal from 
terminally differentiated PC12 cells with corresponding densitometry 
quantification.  PC12 cells were terminally differentiated in NGF as previously 
described in Materials and Methods.  Cells were kept in the presence of NGF (Control 
C), or in absence of NGF for 2, 4, 6 (A), 15, 18, 24 and 48 hours(B).  NSE is Neuron-
Specific Enolase is a loading control.  Minus sign represents withdrawal of NGF.  Each 
bar represents an average of three independent experiments.  Error bars indicate S.E  
(* p< 0.05). 
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Figure 20.  Western blot analysis of Total and Ser63 phosphorylated c-Jun following 
NGF withdrawal with corresponding densitometry quantification.  PC12 cells were 
terminally differentiated in NGF as previously described in Materials and Methods.  Cells 
were kept in the presence of NGF (Control, C), or in absence of NGF for 2, 4, 6 (A), 15, 
18, 24 and 48 hours(B).  α-tubulin is a loading control.  Minus sign represents withdrawal 
of NGF.  Each bar represents an average of three independent experiments.  Error bars 
indicate S.E (* p< 0.05). 
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Differential AT2 expression following NGF and NGF/AngII treatment of PC12 cells, 
reversed by addition of DPI and PD123177 
 
AT2 expression following NGF treatment produced a slight decrease in transcript 
levels initially but expression increased for about one to two fold with NGF addition (Fig 
21A).  On the other hand, NGF/AngII-treated cells produced an earlier upregulation of 
AT2 receptor mRNA increasing transcript levels by six-fold on average (Fig. 21B).  
When earlier time points were investigated, AT2 increase in expression was detected as 
soon as 1h following NGF/AngII treatment (data not shown).  Western blot analysis 
revealed a similar fold increase to the transcript response for both NGF and NGF/Ang II 
addition (Fig. 22 A&B).  The upregulation of AT2 receptor in response to NGF/AngII 
treatment could in part explain the accelerated rate of PC12 cell differentiation observed 
in the previous study. When DPI and PD123177 inibitors were co-administered added 
with NGF/AngII, AT2 expression and protein synthesis were completely downregulated 
(Fig. 23).  
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Figure 21.  RT-PCR analysis of AT2 expression in the presence of NGF or NGF and 
angiotensin II with corresponding densitometry quantification.  PC12 cells were 
cultured as described in Materials and Methods.  Twenty-four hours after seeding, cells 
were kept in regular F-12 K media (C, control) or treated with either NGF-supplemented 
F-12K (50 ng/ml) (A) or NGF (50 ng/ml) and angiotensin II (10 uM) (NGF/AngII) (B)  
for 4, 6, 18, 24, and 48 hours.  Densitometry values are means of three independent 
experiments and represent values corrected for loading control (* p < 0.05).  Equal 
loading control is Neuron Specific Enolase (NSE). 
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Figure 22. Western Blot analysis of AT2 receptor synthesis following NGF and 
NGF/AngII addition with corresponding densitometry analysis.  PC12 cells were 
cultured as described in Materials and Methods.  Twenty-four hours after seeding, cells 
were kept in regular F-12 K media (C, control) or treated with either NGF-supplemented 
F-12K (50 ng/ml) (A) or NGF (50 ng/ml) and angiotensin II (10 uM) (NGF/AngII) (B)  
for 4, 6, 18, 24, and 48 hours. Densitometry values are means of three independent 
experiments.  Asterisk denotes statistical difference from the control.  a-b: Values with 
different letters are significantly different.  (p < 0.05).  α-tubulin is a loading control.  
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Figure 23. DPI and PD123177 downregulate AT2 expression and synthesis. PC12 
cells were cultured as described in Materials and Methods.  Twenty-four hours after 
seeding, cells were kept in regular F-12 K media (C, control) After 24 hours, the cells 
were either kept in regular F-12 K media (Cu, control) or treated with NGF/AngII /DPI 5 
µM, or NGF/AngII /PD- supplemented media at different time-points. Two sets of plates 
per experimental group were prepared to collect RNA and proteins simultaneously. The 
PCR products were initially at 25 cycles, when repeated the cycles were increased to 30 
cycles.  
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AT2 levels increase following NGF withdrawal from PC12 cells 
 
Recent studies demonstrated that the AT2 receptor has an angiotensin II-
dependent and independent roles in cellular apoptosis (Yamada et al., 2000; Miura and 
Karnik, 2000).  The TUNEL assay and the DCF fluorescence results suggested a 
potential role for AT2 receptor activation following NGF withdrawal from terminally 
differentiated PC12 cells.  To further elucidate possible angiotensin II-independent AT2 
upregulation and protein synthesis following NGF removal, we performed RT-PCR and 
western blot analyses.  AT2 transcripts were evident by 18h post-NGF withdrawal (Fig. 
24).  This suggests that AT2 receptors may play a role in the apoptotic effect following 
NGF withdrawal observed in the TUNEL assay. 
 
Discussion 
 
 
NGF/AngII -treated cells produce higher levels of c-jun transcript when compared 
to their NGF-treated counterparts 
 
 
c-jun is an early response gene subject to regulation by external and internal 
stimuli (Angel and Karin, 1991).  The results obtained so far have hinted toward a 
connection between c-Jun and AT2 receptors as two major regulators of apoptosis and 
differentiation.  NGF addition significantly increased c-jun expression as well as protein 
levels. Previous reports linked the increase in c-jun levels to cellular differentiation 
(Leppa et al., 1998).  In addition, NGF/AngII significantly upregulated c-jun transcript 
and produced a gradual increase in protein levels between the two experimental time 
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points of 2h and 4h post-treatment. Overexpression of c-jun in PC12 cells has been 
associated with enhanced induction of neurite growth, which suggests a link between c-
jun overexpression and the accelerated rate of PC12 differentiation observed in the  
 
 
 
 
 
 
 
 
 
 
Figure 24. RT-PCR and western blot analyses of AT2 receptor following NGF 
removal from terminally differentiated PC12 cells. PC12 cells were terminally 
differentiated in NGF as previously described in Materials and Methods.  Cells were kept 
in the presence of NGF (Control, C), or in absence of NGF for 15, 18, 24, and 48 hours 
(A) Neuron Specific Enolase is loading control for the RT-PCR. (B) α-tubulin is the 
loading control for the western blot. Error bars indicate S.E (* p< 0.05). 
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previous study (Dragunow et al., 1993).  However, there are conflicting reports in the 
literature about the complete role of c-jun expression on stimulation of neuronal 
differentiation.  One group argued that c-jun induction is necessary but not sufficient for 
a full activation of the neuronal differentiation cascade (Dragunow et al., 1993).  In 
contrast, another report showed that NGF-dependent c-jun induction was enough to 
stimulate neurite sprouting in PC12 cells (Leppa et al., 1998). The discrepancy has been 
attributed to the type of PC12 cell clone used as one necessitates NGF and cAMP for 
differentiation, while the other requires only NGF (Dragunow et al., 1993). 
c-Jun expression decreases shortly after NGF removal but remains high at later 
stages of apoptosis 
  
Increased JNK activity has been correlated with neuronal death through 
phosphorylation of the N-terminal of c-Jun transcription factor (Carimalo et al., 2005). 
Withdrawal of NGF caused a decrease in c-jun expression at 4h but produced an 
upregulation of the gene at longer time points. This finding was puzzling as c-jun 
expression was expected to increase following NGF withdrawal while cells undergo 
apoptosis.  Western blot analysis revealed similar enigmatic results.  Phospho-Ser63 c-
Jun paralleled the decrease depicted in the RT-PCR; however, total c-Jun levels showed a 
slow decrease.  When shorter time points were performed, the western blot analysis 
depicted a decrease in phospho-Ser63 c-Jun starting after the first hour of NGF removal 
and lasting for about 4 hours.  In fact, there are few reports in the literature that support 
these findings. c-jun expression in neurons undergoing apoptosis after hypoxia-ischemia 
and status epilepticus was delayed and prolonged.  Indeed, those neurons produced a 
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substantial expression of c-Jun in their nuclei peaking at 24h after the insult, which did 
not totally agree with our results as total c-jun showed a steady increase up to the 48h 
time-course (Dragunow et al., 1993).  The same group debated that the type of insult 
differentially upregulates certain immediate early-genes including c-jun.  In addition, 
JNK activity increased twofold in sympathetic neurons following NGF removal and 
reached a peak at 4 and 8 hr after NGF withdrawal, the time at which it was reported that 
c-Jun protein levels and N-terminal phosphorylation started to increase (Rukenstein et al., 
199; Ham et al., 1995).  Our study looked at very early time points, and described an 
increase after the 4h time-point.  However, the apoptosis signaling pathways of PC12 
cells and sympathetic neurons differ. In differentiated PC12 cells, both JNK and p38 
kinase activity increased after NGF withdrawal. However, in the case of sympathetic 
neurons there was no increase detected in p38 kinase activity (Eilers et al., 1998).  Hence, 
the discrepancy is obviously tissue-related.  The slow decrease after 60 min in band 
intensity detected (data not shown) reveals a possible degradation of the protein. The 
parallel response detected by RT-PCR might indicate that the c-jun system is switching 
from survival to apoptotic. When the survival signal is discontinued, c-jun expression is 
halted as well as the phosphorylation of the c-Jun protein.  However, the transcription and 
c-Jun activation resumes when apoptotic signals are activated. The switch happens 
through ERK inactivation and JNK stimulation which was shown to peak at 4h followed 
by an increase in c-Jun proteins (Rukenstein et al., 1991).  
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NGF/AngII produces a premature AT2 expression and synthesis 
 
AT2 receptors have been associated with cellular differentiation and apoptosis 
(Nakajima et al., 1995; Yamada et al., 1996).  The addition of NGF produced an AT2 
receptor upregulation over the course of the experiment which suggests that expression of 
AT2 receptors could be angiotensin II-independent and could be influenced by high 
availability of trophic factors, as is the case during embryogenesis (Nakajima et al., 1995, 
Yamada et al., 1996).  However, administration of NGF/AngII produced an earlier 
upregulation of AT2 expression and synthesis.  The precipitated upregulation of AT2 
expression and synthesis might explain the accelerated rate of PC12 cell differentiation 
observed earlier.  Angiotensin II increases cell surface receptor number by simply 
binding to its receptor (Csikos et al., 1998). AT2 ligands produce very slow dissociation 
which allows them to remain active for a period of time (Hein et al., 1997).   
AT2 expression increases at a later stage of apoptosis at the mRNA and protein 
levels 
 
 Angiotensin II-dependent AT2 receptor implication in PC12 cell apoptosis has 
been well established and documented. Therefore, we systematically examined 
angiotensin II-independent AT2 receptor regulation (Yamada et al., 1996).  In fact, a 
recent report pointed out toward possible angiotensin II-independent implication of these 
receptors in PC12 cell apoptosis (Miura and Karnik, 2000).  Several lines of evidence 
suggests that induction of apoptosis is a constitutive function of AT2 receptor through 
p38 MAPK stimulation.  Conversely, the effect of AT2 receptor on cellular 
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differentiation involves hindering of p38 MAPK signaling. In addition, it was reported 
that p38 MAPK activation is linked to the level of expression of AT2 receptor protein 
and not to activation of the AT2 receptor by the ligand (Miura and Karnik, 2000).  
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The broad significance of this research 
 
Neurodegeneration is a big challenge for researchers and health care providers as 
many of the integrated underlying mechanisms are yet to be identified.  There are a 
number of independent environmental and genetic risk factors proposed. None however 
were confirmed to be the definite perpetrators (Mayeux, 2003).  Nevertheless, the 
oxidative stress theory has gained common ground in the etiology of neurodegeneration 
(Coyle and Puttfarcken, 1993).  However, the machinery of oxidative stress has not been 
fully elucidated.  On the other hand, adult neurogenesis is emerging as a promising 
therapy for brain degenerative diseases.  In fact, neural stem cells were discovered in the 
adult brain and were found to be able to give rise to new neurons, astrocytes, and 
oligodendrocytes, in the same way as a developing brain (Reynolds and Weiss, 1992; 
Richards et al., 1992).  Another significance for this type of research stems from the need 
to “reinforce synapses.”  The implication of this phenomenon ranges from using the brain 
model as a computer to neuronal adaptability and plasticity (Gage, 2002).  Therefore, 
research pertaining to understanding neuronal differentiation as well as halting the onset 
of neurodegeneration is deemed valuable.   
NADPH oxidase contributes to PC12 cells differentiation and apoptosis via oxidative 
stress 
 
 Here we present evidence that NADPH oxidase, through generation of reactive 
oxygen species (ROS), plays a dual role in neuronal-like PC12 cell differentiation and 
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apoptosis. The differentiation study has supplied many missing pieces to the puzzle 
concerning PC12 cell differentiation in relation to NADPH oxidase.  First, it corroborated 
the emmerging reports pointing toward the implication of NADPH oxidase in PC12 cell 
differentiation.  In fact, there are a number of recent published papers that link directly or 
indirectly NADPH oxidase-induced ROS to PC12 cell differentiation (Suzukawa et al., 
2000, Li et al., 2006).  Conversely, no one study has looked at the complete course of 
PC12 cell differentiation in relation to ROS production and gene expression of NADPH 
oxidase.  The current study has identified the potential catalytic subunits involved in 
PC12 cell differentiation.  Nox4 constitutive expression suggests that it is responsible for 
the basal-level of ROS production. Its activity however was reported to be inducible 
(Lambeth, 2004).  The western blot analysis showed that p67-phox is present along with 
Nox4 during the short-term treatment with NGF.  It is possible that NGF treatment leads 
to the production of p67-phox as a potential activator of the enzyme.  When angiotensin 
II was added, Nox4 and p67-phox levels increased, however the major phenomenon 
occurring was the increase in Nox1 and p47-phox levels as a potential way to keep up 
with the increase demand for ROS production.  The long-term treatment with NGF 
produced a parallel pattern of Nox4/p67-phox and Nox1/p47-phox increase.  The long-
term treatment with N/A expedited the synthesis of Nox1, Nox4 and p47-phox.  The 
impact, however on p67-phox was less significant.  Therefore, Nox4 and p67-phox may 
be involved in the initial process of PC12 cell differentiation and possibly in the 
production of basal ROS levels in unstimulated cells.  Nox1 and p47-phox are more 
likely needed for the later and accelerated stage of differentiation.  In fact, the 
combination of NGF and angiotensin II produced a need for an earlier employment of 
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Nox1 and p47 making these two subunits vital parts of the early stages of PC12 
differentiation with NGF and angiotensin II co-treatment. 
The apoptosis study has substantiated many data from experiments performed on 
sympathetic neurons in our laboratory, and provided novel findings about PC12 cell 
apoptosis that should be deemed useful for the understanding of many aspects of 
neurodegeneration.  Indeed, NADPH oxidase is involved in PC12 cell apoptosis as it is 
implicated in sympathetic neuronal death (Tammariello et al., 2000, Hilburger et al., 
2005).  In addition, NADPH oxidase contributes to cell death by means of reactive 
oxygen species production.  The cascade of events including the increase in NADPH 
oxidase synthesis with co-incubation of NGF and the enzyme activator angiotensin II, the 
enhancement of ROS production and the accelerated apoptosis are supportive of this 
finding.  The decrease in ROS production concomitant with the decline in the number of 
apoptotic cells with the use of DPI furthers this strong relationship.  In addition, the rapid 
and sustained increase in the protein levels of the enzyme following NGF-deprivation 
confirms that Nox1, p47 and p67 are the major participants in the apoptotic process.   
    PD123177 was able to diminish to basal levels DCF values when DPI at both 
concentrations failed to so.  Although other investigators have found that AT2 receptors 
are engaged in the process of PC12 cell apoptosis (Horiuchi et al., 1997, Yamada et al., 
1996), our findings, however furthered these data and implies that AT2 receptors in PC12 
cell apoptosis may be independent of angiotensin II.  In addition, the upregulation of AT2 
receptors following NGF withdrawal and the PD123177-induced slower death rate even 
when angiotensin was added provide evidence that AT2 receptors are involved in both 
angiotensin II-dependent and -independent apoptosis of PC12 cells.   
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Future Directions 
 
 Although NADPH oxidase subunits involved in PC12 cell differentiation and 
apoptosis were potentially identified, we still need to gain further knowledge of the 
enzyme activation mechanisms and the kinetics of the catalytic subunits.  The subunit 
kinetics might be responsible for the differential amount and rate of ROS produced in 
differentiation and apoptosis. According to our data, redox signaling is an integral part of 
both differentiation and apoptosis processes.  The signaling pathways activated and 
possibly integrated still need to be identified.  The differential ROS production whereby a 
second burst of ROS was detected in both studies points toward an upregulation of the 
ambient antioxidant system that presumably was insufficient to offset the high production 
of ROS in apoptosis and following angiotensin II addition in differentiation.  Further 
analysis is needed to understand this phenomenon.  The mechanisms of AT2 receptors 
are still not fully understood at the molecular levels, as they appear to be unusual G-
Protein coupled receptors.  The fact that NGF and angiotensin II exhibit a synergistic 
effect that was abolished by an AT2-antagonist demonstrates that there may be a 
signaling pathway cross talk between activated Trk and AT2 receptors.  Further 
investigation is required in this area as some molecular signals could hold the key for 
successful neuronal differentiation or decelerated neurodegeneration.  Finally, the effect 
of DPI or PD123177 on gene expression and protein synthesis of NADPH oxidase should 
be additionally studied.  Preliminary data from RT-PCR analyses revealed Nox1 and 
Nox4 expression decreased following short-term DPI addition.  Furthermore, c-jun 
expression decreased in a dose dependent manner. Analyzing the expression of NADPH 
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oxidase in response to those inhibitors will bring this research to a different level as many 
questions posed previously could be answered.  In fact, controlling the enzyme’s 
expression through redox control or use of inhibitors might prove extremely crucial for 
averting apoptosis. 
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